68 research outputs found

    ์ „๋…ธ์‹ฌ SP3 ๊ณ„์‚ฐ์„ ์œ„ํ•œ ๋ฐฉํ–ฅ๊ต์ฐจ ์ผ์ฐจ์› ์„ ์›ํ™•์žฅ ๋…ธ๋‹ฌ๋ฒ•

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์—๋„ˆ์ง€์‹œ์Šคํ…œ๊ณตํ•™๋ถ€, 2013. 2. ์ฃผํ•œ๊ทœ.3์ฐจ์› ์ „๋…ธ์‹ฌ ์ˆ˜์†ก๊ณ„์‚ฐ์„ ์œ„ํ•œ 1์ฐจ์› ๋ฐฉํ–ฅ ๊ต์ฐจ๋ฒ•์„ ์ด์šฉํ•œ ์ „๊ฒฉ์ž ๊ธฐ๋ฐ˜ SP3 ์„ ์› ํ™•์žฅ ๋…ธ๋‹ฌํ•ด๋ฒ•(SENM)์„ ๊ฐœ๋ฐœํ•˜์˜€๋‹ค. ์ด๋ฅผ ์œ„ํ•ด ๋จผ์ € 3์ฐจ์› SP3 ๋ฐฉ์ •์‹์œผ๋กœ๋ถ€ํ„ฐ ํšก๋ฐฉํ–ฅ์œผ๋กœ ์ ๋ถ„๋œ 1์ฐจ์› SP3 ๋ฐฉ์ •์‹์„ ์œ ๋„ํ•˜์˜€๋‹ค. ํšก๋ฐฉํ–ฅ ์ ๋ถ„ SP3 ๋ฐฉ์ •์‹์— ๋Œ€ํ•œ ๋…ธ๋‹ฌํ•ด๋ฒ•์€ 0์ฐจ์™€ 2์ฐจ ๊ฐ๋ชจ๋ฉ˜ํŠธ๊ฐ€ ๊ฐ๊ฐ 4์ฐจ ๋ฅด์žฅ๋“œ๋ฅด ๋‹คํ•ญ์‹๊ณผ ์ง€์ˆ˜ํ•จ์ˆ˜์˜ ๊ฒฐํ•ฉ์œผ๋กœ ํ‘œํ˜„๋˜์–ด ๊ธ‰๊ฒฉํ•œ ๋ณ€ํ™”๋ฅผ ๊ฐ€์ง€๋Š” ์ค‘์„ฑ์ž์† ๊ทผ์‚ฌ์— ์ ํ•ฉํ•œ ์„ ์›ํ™•์žฅ ๋…ธ๋‹ฌ๋ฒ•์„ 1์ฐจ์› ์ „๊ฒฉ์ž์— ๋Œ€ํ•ด ์ ์šฉํ•˜์—ฌ ๋™์‹œํ•ด๋ฅผ ๊ตฌํ•  ์ˆ˜ ์žˆ๋„๋ก ๊ตฌ์„ฑํ•˜์˜€๋‹ค. 3์ฐจ์› ๋…ธ์‹ฌ ๊ณ„์‚ฐ์„ ์œ„ํ•ด์„œ๋Š” 1์ฐจ์› SP3 ์„ ์›ํ™•์žฅ ๋…ธ๋‹ฌํ•ด๋ฅผ ์‚ผ์ฐจ์›์˜ x, y, z ๊ฐ ๋ฐฉํ–ฅ์— ๋Œ€ํ•ด ๊ต์ฐจ๋กœ ๊ตฌํ•˜๋˜ ์ด์ „์˜ ์ˆ˜์ง๋ฐฉํ–ฅ์˜ ํ•ด๋กœ๋ถ€ํ„ฐ ํšก๋ฐฉํ–ฅ ์ ๋ถ„ ๋ฐฉ์ •์‹ ์šฐ๋ณ€์˜ ํšก๋ฐฉํ–ฅ ๋ˆ„์„คํ•ญ์„ ๊ฐฑ์‹ ํ•˜์—ฌ ํ•ด๋‹น๋ฐฉํ–ฅ์˜ ํ•ด๋ฅผ ๊ตฌํ•˜๊ณ  ์„ธ ๋ฐฉํ–ฅ์— ๋Œ€ํ•œ 1์ฐจ์› SENM ํ•ด๋กœ๋ถ€ํ„ฐ ๊ตฌํ•ด์ง„ ๊ฐ๋ฐฉํ–ฅ ์ˆœ์ค‘์„ฑ์ž๋ฅ˜๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ๊ฐ ์†Œ๊ฒฉ๊ฒฉ์ž์˜ ์ค‘์„ฑ์ž ๊ท ํ˜•๋ฐฉ์ •์‹์˜ ํ•ด๋ฅผ ๋…๋ฆฝ์ ์œผ๋กœ ๊ตฌํ•ด ์ค‘์„ฑ์ž์† ๊ฐ๋ชจ๋ฉ˜ํŠธ๋ฅผ ๊ฐฑ์‹ ํ•˜๋Š” ๋ฐฉํ–ฅ๊ต์ฐจ ํ•ด๋ฒ•์„ ๊ณ ์•ˆํ•˜์˜€๋‹ค. ์ด ๋ฐฉํ–ฅ๊ต์ฐจ ํ•ด๋ฒ•์˜ ๋ฐ˜๋ณต์  ์ ์šฉ๋งŒ์œผ๋กœ๋„ ์œ ํšจ์ฆ๋ฐฐ๊ณ„์ˆ˜์™€ ์ค‘์„ฑ์ž์† ๋ถ„ํฌ๋ฅผ ๊ตฌํ•  ์ˆ˜ ์žˆ์œผ๋‚˜ ๊ทธ ์ˆ˜๋ ด์†๋„๊ฐ€ ๋Šฆ์€ ๋ฐ” ์ด๋ฅผ ํ•ด๊ฒฐํ•˜๊ธฐ ์œ„ํ•ด P1 CMFD ๊ณ„์‚ฐ์„ ํ†ตํ•ด ๋…ธ๋‹ฌ๊ณ„์‚ฐ์˜ ํ•ต๋ถ„์—ด์„ ์›๋ถ„ํฌ๋ฅผ ์ˆ˜๋ ด์„ ๊ฐ€์†์‹œํ‚ค๋Š” ๋ฐฉ๋ฒ•์„ ๊ฐœ๋ฐœํ•˜์˜€๋‹ค. P1 CMFD ๊ณ„์‚ฐ์—์„œ๋Š” 2์ฐจ ๊ฐ๋ชจ๋ฉ˜ํŠธ๋ฅผ ๋ฏธ์ง€์ˆ˜๋กœ ์ทจํ•˜์ง€ ์•Š์œผ๋ฏ€๋กœ ํ›„์† ๋ฐฉํ–ฅ ๊ต์ฐจ SENM ๋…ธ๋‹ฌ ๊ณ„์‚ฐ์—์„œ 2์ฐจ ๊ฐ๋ชจ๋ฉ˜ํŠธ ๊ฐฑ์‹ ์ด ๊ฐ€๋Šฅํ•˜์ง€ ์•Š์ง€๋งŒ ๋ฐฉํ–ฅ๊ต์ฐจ ๋…ธ๋‹ฌ๊ณ„์‚ฐ์„ ๋ณต์ˆ˜๋กœ ํ•จ์œผ๋กœ์จ 2์ฐจ ๊ฐ๋ชจ๋ฉ˜ํŠธ๊ฐ€ ์ž์ฒด์ ์œผ๋กœ ๊ฐฑ์‹ ๋˜๋„๋ก ํ•จ์œผ๋กœ์จ P1 CMFD ๊ณ„์‚ฐ๊ณผ ํ†ตํ•ฉ๋œ ๋ฐฉํ–ฅ๊ต์ฐจ 1์ฐจ์› SENM์˜ ์ˆ˜๋ ด์„ฑ์„ ํ™•๋ณดํ•˜์˜€๋‹ค. ์ด ๋ฐฉ๋ฒ•์„ ๊ตฌํ˜„ํ•œ ์ „์‚ฐ์ฝ”๋“œ๋Š” IAEA PWR ๋ฌธ์ œ, C5G7 MOX ๋ฌธ์ œ, KAIST 4G ๋ฌธ์ œ, MOX ๋…ธ์‹ฌ ๊ณผ๋„ํ•ด์„ ํ‘œ์ค€๊ฒ€์ฆ๋ฌธ์ œ, TAKEDA ๊ณ ์†๋กœ ๋ฌธ์ œ๋“ฑ์˜ 2์ฐจ์› ๋ฐ 3์ฐจ์› ๋ฒค์น˜๋งˆํฌ ๋ฌธ์ œ์— ๋Œ€ํ•ด ๊ทธ ์ •ํ™•๋„์™€ ์‹ ์†์„ฑ์„ ๊ฒ€์ฆํ•˜์˜€๋‹ค. 2์ฐจ์› ๋ฒค์น˜๋งˆํฌ ๋ฌธ์ œ๋Œ€ํ•ด์„œ๋Š” ๋ฏธ์„ธ๊ฒฉ์ž ์œ ํ•œ์ฐจ๋ถ„ํ•ด๊ฐ€ ๊ฐ€๋Šฅํ•˜๋ฏ€๋กœ ์ด๋ฅผ ํ†ตํ•ด SP3 ๊ธฐ์ค€ํ•ด๋ฅผ ์ƒ์„ฑํ•˜์—ฌ ๋…ธ๋‹ฌํ•ด์˜ ๋น„๊ต๋Œ€์ƒ์œผ๋กœ ์ทจํ–ˆ๊ณ  3์ฐจ์› ๋ฒค์น˜๋งˆํฌ ๋ฌธ์ œ๋Š” ๋ชฌํ…Œ์นผ๋กœ ํ•ด๋ฒ•์„ ํ†ตํ•ด ๊ธฐ์ค€ํ•ด๋ฅผ ์ƒ์„ฑํ•˜์˜€๋‹ค. ์ด๋Ÿฐ ๊ฒ€์ฆ ๊ณผ์ •์„ ํ†ตํ•ด ๋ฐฉํ–ฅ๊ต์ฐจ ์ผ์ฐจ์› ์„ ์›ํ™•์žฅ ๋…ธ๋‹ฌ๋ฒ•์ด ์‹ ์†ํ•˜๊ณ  ์ •ํ™•ํ•œ SP3 ํ•ด๋ฒ•์ž„์„ ํ™•์ธํ•˜์˜€๋‹ค. ๋˜ํ•œ, CMFD์™€ ๊ฒฐํ•ฉํ•˜์ง€ ์•Š์€ ๋ฐฉ๋ฒ•๊ณผ์˜ ๋น„๊ต๋ฅผ ํ†ตํ•ด์„œ ๊ฐœ๋ฐœํ•œ ๋…ธ๋‹ฌ ๊ณ„์‚ฐ๋ฒ•์—์„œ์˜ CMFD์˜ ๋งค์šฐ ์šฐ์ˆ˜ํ•œ ๊ฐ€์† ์„ฑ๋Šฅ๋„ ํ™•์ธํ•˜์˜€๋‹ค.์ œ 1 ์žฅ ์„œ ๋ก  1 ์ œ 1 ์ ˆ ์—ฐ๊ตฌ ๋ฐฐ๊ฒฝ๊ณผ ๋ชฉ์  1 ์ œ 2 ์ ˆ ์—ฐ๊ตฌ ๋…ผ์ ๊ณผ ํ•ด๊ฒฐ๋ฐฉ์•ˆ 3 ์ œ 3 ์ ˆ ๋…ผ๋ฌธ์˜ ๊ตฌ์„ฑ 4 ์ œ 2 ์žฅ SP3 ๋ฐฉ์ •์‹๊ณผ ์œ ํ•œ ์ฐจ๋ถ„ ํ•ด๋ฒ• 6 ์ œ 1 ์ ˆ 1์ฐจ์› PL ๋ฐฉ์ •์‹์˜ ์œ ๋„ 6 ์ œ 2 ์ ˆ ๋‹ค์ฐจ์› SP3 ๋ฐฉ์ •์‹ 11 ์ œ 3 ์ ˆ SP3 ๋ฐฉ์ •์‹์˜ ์œ ํ•œ ์ฐจ๋ถ„ ํ•ด๋ฒ• 14 ์ œ 3 ์žฅ 1์ฐจ์› ์ „๊ฒฉ์ž ๊ธฐ๋ฐ˜ SP3 ์„ ์›ํ™•์žฅ ๋…ธ๋‹ฌ๋ฒ• 18 ์ œ 1 ์ ˆ ํšก๋ฐฉํ–ฅ ์ ๋ถ„ 1์ฐจ์› SP3 ๋ฐฉ์ •์‹ 18 ์ œ 2 ์ ˆ ์„ ์›ํ™•์žฅ ๋…ธ๋‹ฌ๋ฒ• 20 ์ œ 3 ์ ˆ ์ „๊ฒฉ์ž ๋ฐฉ์‹์˜ ๋™์ฐจํ•ด ๊ณ„์ˆ˜ ๊ฒฐ์ • 26 ์ œ 4 ์žฅ ๋ฐฉํ–ฅ ๊ต์ฐจ ๊ณ„์‚ฐ ์ฒด๊ณ„ 33 ์ œ 1 ์ ˆ P1 ๊ธฐ๋ฐ˜ CMFD๋ฅผ ์ด์šฉํ•œ ๋ฐฉํ–ฅ ๊ต์ฐจ ๊ณ„์‚ฐ ์ฒด๊ณ„ 33 ์ œ 2 ์ ˆ ๋…ธ๋‹ฌ ๊ท ํ˜• ๋ฐฉ์ •์‹์„ ์ด์šฉํ•œ ๋ฐฉํ–ฅ ๊ต์ฐจ ๊ณ„์‚ฐ ์ฒด๊ณ„ 38 ์ œ 5 ์žฅ ์ˆ˜์น˜ ๊ณ„์‚ฐ ๊ฒฐ๊ณผ 41 ์ œ 1 ์ ˆ SP3 ํ•ด๋ฒ•์˜ ์šฐ์ˆ˜์„ฑ ๊ฒ€์ฆ 42 ์ œ 2 ์ ˆ 2์ฐจ์› ๋ฒค์น˜๋งˆํฌ ๋ฌธ์ œ ๊ฒ€์ฆ 46 ์ œ 3 ์ ˆ 3์ฐจ์› ๋ฒค์น˜๋งˆํฌ ๋ฌธ์ œ ๊ฒ€์ฆ 60 ์ œ 4 ์ ˆ CMFD ๊ณ„์‚ฐ์˜ ๊ฐ€์† ์„ฑ๋Šฅ ํ‰๊ฐ€ 62 ์ œ 6 ์žฅ ๊ฒฐ ๋ก  67Maste

    ๋‹ค ํƒœ์•„ ์ž„์‹ ์—์„œ ๋ชจ์ฒดํ˜ˆ์žฅ ๋‚ด ์œ ๋ฆฌ DNA์˜ ์ฐจ์„ธ๋Œ€ ์—ผ๊ธฐ๋ฐฐ์—ด ๋ถ„์„๋ฐฉ๋ฒ•์„ ์ด์šฉํ•œ ๋น„ ์นจ์Šต์  ์‚ฐ์ „๊ฒ€์‚ฌ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์˜ํ•™๊ณผ ์‚ฐ๋ถ€์ธ๊ณผํ•™์ „๊ณต, 2016. 8. ๋ฐ•์ค‘์‹ .Objective The objective of this study is to evaluate the performance of non-invasive prenatal testing (NIPT) for trisomies 21, 18 and 13 by using next-generation sequencing of cell-free DNA from maternal plasma in multifetal pregnancies. Method A double-blind prospective study was performed from 2014 November to 2015 June. Among a cohort of 211 high-risk pregnancies, 23 multifetal pregnant women who were expected to undergo invasive procedures for fetal karyotype diagnosis, were recruited. At same time, invasive procedures and maternal plasma DNA sequencing were performed to detect trisomies 21 ,18 and 13. For each target chromosome 21, 18, 13 z-scores of 3 or higher were classified with trisomy high risk and z-scores of 2 over less than 3 were classified with trisomy potential high risk. The fetal karyotype of invasive test was used as gold standard to confirm the detection rate, false negative and false positive of sequencing-based non-invasive prenatal test. Results There were 3 monochorionic diamniotic (MCDA) twins, 19 dichorionic diamniotic (DCDA) twins and 1 trichorionic triamniotic (TCTA) triplets. There were two discordant twins of trisomy 21 confirmed by karyotyping. Plasma DNA sequencing correctly identified two cases of trisomy 21. The maternal plasma DNA sequencing for fetal trisomy 21 showed 100% accurate detection respectively. Conclusion Although study size is limited, this study showed that NIPT could be applicable to multifetal pregnancies with accurate detection and further supported that sequencing-based NIPT of trisomy 21 in multifetal pregnancies could be achieved with a high accurate efficiency, which could effectively avoid invasive prenatal diagnosis procedures.Introduction 1 Methods 3 Results 6 Discussion 8 Conclusion 11 References 12 Table and Figure 15 Abstract in Korean 21Maste

    DEAใƒขใƒ‡ใƒซใช็”จใ„ใŸ ๆ—ฅๆœฌ๏คŠ่žๆŒๆ ชๆœƒ็คพใฎ ๆ•ˆ๏ง›ๆ€ง ๅˆ†ๆž

    No full text
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ๊ตญ์ œํ•™๊ณผ(๊ตญ์ œ์ง€์—ญํ•™์ „๊ณต), 2011.8. ๊น€ํ˜„์ฒ .Maste

    -ํ˜•ํ‰์„ฑ ๊ธฐ์ค€๊ณผ์˜ ์–‘๋ฆฝ๊ฐ€๋Šฅ์„ฑ์— ๋Œ€ํ•œ ์‹ค์ฆ์  ๋ถ„์„-

    No full text
    ๋ณต์ง€๋ฅผ ์œ„ํ•œ ์žฌ์› ๋ฐฐ๋ถ„ ์ •์ฑ…์—์„œ ์ •๋ถ€์˜ ๊ณต์  ์ด์ „์ง€์ถœ์€ ํ˜•ํ‰์„ฑ(equality)์„ ์ถ”๊ตฌํ•  ์ˆ˜๋Š” ์žˆ์œผ๋‚˜ ์‚ฌํšŒ ์ „์ฒด์˜ ํšจ์œจ์„ฑ(efficiency)์„ ์ €ํ•ดํ•œ๋‹ค๋Š” ๋…ผ์˜๊ฐ€ ๋งŽ์ด ์žˆ์–ด์™”๋‹ค. ๊ทธ๋Ÿฌ๋‚˜, ํ˜•ํ‰์„ฑ๊ณผ ํšจ์œจ์„ฑ์˜ ์ƒ์ถฉ๊ด€๊ณ„๊ฐ€ ๋ชจ๋“  ์ข…๋ฅ˜์˜ ๋ณต์ง€๋ฅผ ์œ„ํ•œ ์žฌ์› ๋ฐฐ๋ถ„ ์ •์ฑ…์— ์ ์šฉ๋œ๋‹ค๊ณ ๋Š” ํ•  ์ˆ˜ ์—†๋‹ค. ๊ณต์  ์ด์ „์ง€์ถœ์ด ์ •์น˜์ ์œผ๋กœ ๊ฒฐ์ •๋˜๋Š” ๊ฒฝ์šฐ ์ˆ˜ํ˜œ์ž ์ง‘๋‹จ๋ณ„๋กœ ๋‚˜ํƒ€๋‚˜๋Š” ๋…ธ๋™ ๊ณต๊ธ‰์˜ ๊ฐ์†Œ์™€ ๊ฐ™์€ ์—ฌ๋Ÿฌ ๊ฐ€์ง€ ํ–‰ํƒœ ๋ณ€ํ™”(Behavioral Change) ๋“ฑ, ์ •์ฑ…์— ๋Œ€ํ•œ ๋ฐ˜์‘์˜ ์ •๋„(Response to the Policy)์— ๋Œ€ํ•œ ๊ณ ๋ ค์—†์ด ๊ธ‰์—ฌ ์ง€๊ธ‰์ด ์ด๋ฃจ์–ด์ง€๊ฒŒ ๋œ๋‹ค๋ฉด, ์ด๋Ÿฌํ•œ ๊ฒฝ์šฐ ํšจ์œจ์„ฑ์˜ ์†์‹ค์ด ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜, ์ผ๋ฐ˜์ ์œผ๋กœ ์ €์†Œ๋“์ธต์˜ ์žฅ์• ์ธ, ๋…ธ์ธ, ์—ฌ์„ฑ ๋“ฑ์ด ์ˆ˜ํ˜œ์ž์ธ ๊ฒฝ์šฐ ์ด๋“ค์ด ๊ทผ๋กœ๋Šฅ๋ ฅ์ด ๋‚ฎ๊ฑฐ๋‚˜ ๊ทผ๋กœ ๊ธฐํšŒ๊ฐ€ ๋” ์ ๋‹ค๋ฉด ์ •๋ถ€๋กœ๋ถ€ํ„ฐ ๊ณต์  ์ด์ „์ง€์ถœ ๊ธ‰์—ฌ๋ฅผ ์ง€์›๋ฐ›๋”๋ผ๋„ ํ–‰ํƒœ ๋ณ€ํ™”์˜ ์ •๋„๊ฐ€ ๋” ๋‚ฎ๊ฒŒ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค(Blank, 2002). ๋”ฐ๋ผ์„œ ํšจ์œจ์„ฑ ์†์‹ค ์ •๋„๊ฐ€ ๋‚ฎ์„ ์ˆ˜ ์žˆ๋Š” ์ง‘๋‹จ์— ๋” ๋งŽ์€ ์žฌ์›์„ ๋ฐฐ๋ถ„ํ•˜๋Š” ๊ฒƒ์ด ํ˜•ํ‰์„ฑ๊ณผ ํšจ์œจ์„ฑ์„ ๋ชจ๋‘ ์ถ”๊ตฌํ•  ์ˆ˜ ์žˆ๋Š” ๋ฐฉ์•ˆ์ด ๋  ์ˆ˜ ์žˆ๋‹ค. ์ฆ‰, ๋Œ€์ƒ์ž์˜ ์„ ์ •(targeting)๋ฌธ์ œ๊ฐ€ ํšจ์œจ์„ฑ๊ณผ ํ˜•ํ‰์„ฑ์˜ ์ถ”๊ตฌ์— ๋งค์šฐ ์ค‘์š”ํ•œ ์—ญํ• ์„ ํ•  ์ˆ˜ ์žˆ๋Š” ๊ฒƒ์ด๋‹ค. ๋ณธ ๋…ผ๋ฌธ์—์„œ๋Š” ์ €์†Œ๋“์ธต์„ ๋ฐฐ๋ คํ•˜๊ธฐ ์œ„ํ•œ ๋ณต์ง€ ์žฌ์›์˜ ๋ฐฐ๋ถ„ ์ •์ฑ…์—์„œ ํ˜•ํ‰์„ฑ๊ณผ ํšจ์œจ์„ฑ์˜ ์ถ”๊ตฌ๊ฐ€ ์„œ๋กœ ์ƒ์ถฉ๋˜์ง€ ์•Š๊ณ  ํ•จ๊ป˜ ์–‘๋ฆฝํ•  ์ˆ˜ ์žˆ๋Š”์ง€ ์—ฌ๋ถ€๋ฅผ ์‹ค์ฆ ์ž๋ฃŒ๋ฅผ ํ†ตํ•˜์—ฌ ๋ถ„์„ํ•˜์˜€๋‹ค. ์ด๋ฅผ ์œ„ํ•˜์—ฌ ์šฐ๋ฆฌ๋‚˜๋ผ์—์„œ ์‹ค์‹œ๋˜๊ณ  ์žˆ๋Š” ๊ตญ๋ฏผ๊ธฐ์ดˆ์ƒํ™œ๋ณด์žฅ์ œ๋„์˜ ํ˜„๊ธˆ ์ด์ „ ๊ธ‰์—ฌ, ์กฐ๊ฑด๋ถ€ ์ด์ „ ๊ธ‰์—ฌ, ์ง์—…ํ›ˆ๋ จ ๊ธ‰์—ฌ ๋“ฑ ๊ณต์  ์ด์ „์ง€์ถœ ์ œ๋„๋ฅผ ์‚ดํŽด๋ณด๊ณ  ์ด ์ œ๋„๋“ค์„ ์ˆ˜๊ธ‰ํ•˜๋Š” ์ˆ˜๊ธ‰์ž๋“ค์„ ์„ฑ๋ณ„(๋‚จ์„ฑ, ์—ฌ์„ฑ), ์—ฐ๋ น๋ณ„(์ฒญ์žฅ๋…„, ๋…ธ๋…„), ์žฅ์• ์—ฌ๋ถ€๋ณ„(์žฅ์• ์ธ, ๋น„์žฅ์• ์ธ)๋กœ ์„ธ ์ง‘๋‹จ์œผ๋กœ ๋‚˜๋ˆ„๊ณ  ๋‹ค์‹œ ์ด๋“ค์„ ์ˆ˜๊ธ‰์ž ์ง‘๋‹จ๊ณผ ๋น„์ˆ˜๊ธ‰์ž ์ง‘๋‹จ์œผ๋กœ ๋‚˜๋ˆ„์–ด ๋…ธ๋™ ๊ณต๊ธ‰์˜ ๋ณ€ํ™” ์ •๋„๋ฅผ ์‹ค์ฆ์ ์œผ๋กœ ๋ถ„์„ํ•˜์˜€๋‹ค. ๋ถ„์„ ์ž๋ฃŒ๋กœ๋Š” ํ•œ๊ตญ๋ณต์ง€ํŒจ๋„ ์ž๋ฃŒ ๋ฐ ํ•œ๊ตญ๋…ธ๋™ํŒจ๋„ ์ž๋ฃŒ๋ฅผ ํ™œ์šฉํ•˜์—ฌ ๊ณ ์ •ํšจ๊ณผ ๋ชจํ˜•์„ ์ ์šฉํ•˜์—ฌ ๋ถ„์„ํ•˜์˜€๋‹ค. ๋ถ„์„ ๊ฒฐ๊ณผ, ๊ณต์ ์ด์ „ ์ง€์ถœ ์ œ๋„์˜ ๊ธ์ •์  ์œ ์ธ(Positive Incentive)์˜ ํšจ๊ณผ๋Š” ์„ฑ๋ณ„, ์—ฐ๋ น๋ณ„, ์žฅ์• ์—ฌ๋ถ€๋ณ„ ๋ถ„์„์—์„œ ๋Œ€์ฒด๋กœ ์—ฌ์„ฑ, ๋…ธ๋…„์ธต, ์žฅ์• ์ธ์˜ ๊ฒฝ์šฐ์—์„œ ๋‚จ์„ฑ, ์ฒญ์žฅ๋…„์ธต, ๋น„์žฅ์• ์ธ๋ณด๋‹ค ๋” ๋งŽ์ด ๋‚˜ํƒ€๋‚˜๊ณ  ์žˆ์—ˆ๋‹ค. ๊ทธ๋Ÿฌ๋ฏ€๋กœ ์ •์ฑ…์ ์œผ๋กœ ์ด๋“ค์„ ๋Œ€์ƒ์œผ๋กœ ํ•˜๋Š” ๊ณต์  ์ด์ „์ง€์ถœ์ œ๋„๊ฐ€ ํ˜•ํ‰์„ฑ์„ ์ถ”๊ตฌํ•˜๋ฉด์„œ๋„ ์ƒ๋Œ€์ ์œผ๋กœ ๋…ธ๋™ ๊ณต๊ธ‰ ํšจ๊ณผ ์ธก๋ฉด์—์„œ๋Š” ํšจ์œจ์„ฑ์„ ํ•จ๊ป˜ ๋‹ฌ์„ฑํ•  ์ˆ˜ ์žˆ์Œ์„ ์‹œ์‚ฌํ•˜๊ณ  ์žˆ๋‹ค.Docto

    Research of Bicycle Pictogram for the Public Design of Bicycle City

    No full text

    A Study of Measuring the Level and Explorig the Determinants of Public Smart Phone App Maturity of the Local Government

    No full text
    ํ•™์œ„๋…ผ๋ฌธ (์„์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ํ–‰์ •๋Œ€ํ•™์› : ํ–‰์ •ํ•™๊ณผ(์ •์ฑ…ํ•™์ „๊ณต), 2015. 8. ์—„์„์ง„.๋ณธ ์—ฐ๊ตฌ๋Š” ๋ชจ๋ฐ”์ผ ๊ธฐ๊ธฐ๊ฐ€ ์„œ๋น„์Šค ์ „๋‹ฌ์˜ ์ˆ˜๋‹จ์ด ๋˜๋Š” ๋ชจ๋ฐ”์ผ์ •๋ถ€ ์‹œ๋Œ€์— ๋Œ€ํ•ด ์‹ค์ฆ์ ์œผ๋กœ ๋ถ„์„ํ•˜๊ณ ์ž ํ•œ๋‹ค. ๊ตฌ์ฒด์ ์œผ๋กœ ๋ณธ ์—ฐ๊ตฌ๋Š” ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์„œ๋น„์Šค์˜ ์ƒˆ๋กœ์šด ์ „๋‹ฌ ์ˆ˜๋‹จ์ธ ๊ณต๊ณต ์Šค๋งˆํŠธํฐ ์• ํ”Œ๋ฆฌ์ผ€์ด์…˜(์ดํ•˜ ๊ณต๊ณต ์•ฑ)์˜ ํ˜„ํ™ฉ ๋ฐ ์ˆ˜์ค€์„ ํŒŒ์•…ํ•˜๊ณ , ์ˆ˜์ค€์— ๋Œ€ํ•œ ๊ฒฐ์ • ์š”์ธ์„ ์‹ค์ฆ์ ์œผ๋กœ ์ ‘๊ทผํ•˜๊ณ ์ž ํ•œ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์˜ ๋‚ด์šฉ์€ ๋‹ค์Œ๊ณผ ๊ฐ™์ด ๊ตฌ์„ฑ๋œ๋‹ค. ์ฒซ์งธ, ๊ด‘์—ญ ๋ฐ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ „์ˆ˜์กฐ์‚ฌ๋ฅผ ํ†ตํ•ด 2015๋…„์„ ๊ธฐ์ค€์œผ๋กœ ์ œ๊ณต๋˜๊ณ  ์žˆ๋Š” ๋ชจ๋ฐ”์ผ ์ •๋ถ€ ์„œ๋น„์Šค์˜ ํ˜„ํ™ฉ์„ ํŒŒ์•…ํ•œ๋‹ค. ์„ธ๋ถ€ ํ•ญ๋ชฉ์œผ๋กœ๋Š” ๊ณต๊ณต ์•ฑ์˜ ์ œ์ž‘๊ธฐ๊ด€, ๊ณต๊ณต ์•ฑ์˜ ์œ ํ˜•, ๋‹ค์šด๋กœ๋“œ ๊ฑด์ˆ˜๋ฅผ ํŒŒ์•…ํ•œ๋‹ค. ๋‘˜์งธ, ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์—์„œ ์ œ๊ณตํ•˜๊ณ  ์žˆ๋Š” ๊ณต๊ณต ์•ฑ์˜ ์ˆ˜์ค€์„ ํŒŒ์•…ํ•œ๋‹ค. ๊ณต๊ณต ์•ฑ์˜ ์ˆ˜์ค€์„ ์ฒด๊ณ„์ ์œผ๋กœ ์ธก์ •ํ•˜๊ธฐ ์œ„ํ•ด, Eom&Kim(2013)์˜ ์—ฐ๊ตฌ์—์„œ ์ •๋ฆฝํ•œ ๊ณต๊ณต ์•ฑ ๋ฐœ์ „๋‹จ๊ณ„ ๋ชจํ˜•์„ ํ† ๋Œ€๋กœ ๊ฐ๊ฐ 1๋‹จ๊ณ„๋ถ€ํ„ฐ 6๋‹จ๊ณ„๋ฅผ ๋ถ€์—ฌํ•œ๋‹ค. ๊ณต๊ณต ์•ฑ ๋ฐœ์ „๋‹จ๊ณ„ ๋ชจํ˜•์€ ๊ธฐ์กด์˜ ์ „์ž์ •๋ถ€ ๋ฐœ์ „๋‹จ๊ณ„๋ฅผ ๋ฐœ์ „์‹œ์ผœ ์‹œ๋ฏผ๋“ค์˜ ํŽธ๋ฆฌ์„ฑ ๋ฐ ์ฐธ์—ฌ๋ฅผ ์œ ๋„ํ•˜๋Š” ๊ธฐ๋Šฅ์— ๋”ฐ๋ผ ๋‹จ๊ณ„๊ฐ€ ๋ฐœ์ „ํ•˜๋Š” ๋ชจํ˜•์œผ๋กœ ๊ตฌ์„ฑ๋œ๋‹ค. ์…‹์งธ, ์ •๋ณด์‹œ์Šคํ…œ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ์ธก์ •๊ณผ ๊ฒฐ์ •์š”์ธ์— ๊ด€ํ•œ ๊ธฐ์กด ์ด๋ก  ๋ฐ ๋…ผ์˜๋“ค์„ ๊ธฐ๋ฐ˜์œผ๋กœ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฒฐ์ • ์š”์ธ์„ ๋„์ถœํ•œ๋‹ค. ์ด๋ฅผ ๋ฐ”ํƒ•์œผ๋กœ ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฒฐ์ •์š”์ธ์„ ๋ถ„์„ํ•œ๋‹ค. ๋ถ„์„ ๊ฒฐ๊ณผ์— ์˜ํ•˜๋ฉด ๊ตญ๋‚ด ๊ด‘์—ญ ๋ฐ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ์€ ํ™œ๋ฐœํ•˜๊ฒŒ ์ œ๊ณต๋˜๊ณ  ์žˆ์—ˆ๋‹ค. ์ „์ˆ˜ ์กฐ์‚ฌ ๊ฒฐ๊ณผ์— ์˜ํ•˜๋ฉด 2015๋…„ 3์›”์„ ๊ธฐ์ค€์œผ๋กœ ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์—์„œ ์ œ๊ณตํ•˜๋Š” ๊ณต๊ณต ์•ฑ์˜ ์ˆ˜๋Š” ์ด 162๊ฐœ, ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์—์„œ ์ œ๊ณตํ•˜๋Š” ๊ณต๊ณต ์•ฑ์˜ ์ˆ˜๋Š” 372๊ฐœ๋กœ์„œ ์ด 534๊ฐœ๊ฐ€ ์ œ๊ณต๋˜๊ณ  ์žˆ์—ˆ๊ณ , ์•ฝ 22๊ฐœ์˜ ๋‹ค์–‘ํ•œ ์œ ํ˜•์˜ ์„œ๋น„์Šค๋ฅผ ์ œ๊ณตํ•˜๊ณ  ์žˆ์—ˆ๋‹ค. ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€์„ ์ธก์ •ํ•œ ๊ฒฐ๊ณผ, ์ƒํ˜ธ ์†Œํ†ต์ด ๊ณ ๋„ํ™” ๋˜๋Š” ๋‹จ๊ณ„์ธ 4๋‹จ๊ณ„์— ํ•ด๋‹นํ•˜๋Š” ๊ณต๊ณต ์•ฑ์ด ์ „์ฒด ๊ณต๊ณต ์•ฑ ์ค‘ ์•ฝ 40% ์ด์ƒ์„ ์ฐจ์ง€ํ•œ ๊ฒƒ์œผ๋กœ ํŒŒ์•…๋˜์—ˆ๋‹ค. ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ๊ฒฐ์ •์š”์ธ์„ ํŒŒ์•…ํ•˜๊ธฐ ์œ„ํ•ด ์ •๋ณด ์‹œ์Šคํ…œ ์ˆ˜์ค€ ๋ฐ ๊ฒฐ์ •์š”์ธ์— ๋Œ€ํ•œ ์„ ํ–‰์—ฐ๊ตฌ๋ฅผ ํ† ๋Œ€๋กœ ์ •๋ณด ๋ฐ ๊ธฐ์ˆ  ์š”์ธ, ์กฐ์ง ์š”์ธ, ์ œ๋„ ์š”์ธ, ํ™˜๊ฒฝ ์š”์ธ์„ ๋„์ถœํ•˜์˜€๋‹ค. ๋„ค ๊ฐ€์ง€์˜ ์š”์ธ์„ ํˆฌ์ž…ํ•˜์—ฌ ์ˆœ์„œ ๋กœ์ง€์Šคํ‹ฑ ํšŒ๊ท€๋ถ„์„์„ ์‹ค์‹œํ•œ ๊ฒฐ๊ณผ์— ๋”ฐ๋ฅด๋ฉด ๊ด‘์—ญ ๋ฐ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ์€ ๊ณตํ†ต๋œ ์š”์ธ์— ์˜ํ•ด ์˜ํ–ฅ์„ ๋ฐ›๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚œ ํ•œํŽธ ์ฐจ์ด์ ๋„ ๋ฐํ˜€์กŒ๋‹ค. ์šฐ์„ ์ ์œผ๋กœ ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ๊ฒฐ์ • ์š”์ธ์— ๋Œ€ํ•œ ์ˆœ์„œ ๋กœ์ง€์Šคํ‹ฑ ํšŒ๊ท€๋ถ„์„ ๊ฒฐ๊ณผ์— ๋”ฐ๋ฅด๋ฉด ๋‹ค์Œ๊ณผ ๊ฐ™๋‹ค. ์ •๋ณด์šฉ๋Ÿ‰, ์ •๋ณดํ™” ๋‹ด๋‹น ์ธ๋ ฅ๋น„์œจ, ์ •๋ณดํ™” ์‚ฌ์—… ์˜ˆ์‚ฐ ๋น„์œจ, CIO์˜ ์ง๊ธ‰ ์ค‘ 3๊ธ‰, ์ •๋ณดํ™” ๊ด€๋ จ ๋ฒ•๋ น ์ˆ˜, GRDP๊ฐ€ ๋†’์„์ˆ˜๋ก ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ์ด ๋†’์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์œผ๋กœ ํŒŒ์•…๋˜์—ˆ๋‹ค. ๋ฐ˜๋ฉด, ์—ฌํ–‰ ๋ฐ ์ง€์—ญ์ •๋ณด ์œ ํ˜•์˜ ๋ฒ”์ฃผ, ์ •๋ณดํ™” ๋‹ด๋‹น ์ธ๋ ฅ, ์ •๋ณดํ™” ๊ด€๋ จ ์ถ”์ง„ ์‚ฌ์—…๊ฑด์ˆ˜์™€ ์˜ˆ์‚ฐ๋น„์œจ, CIO์˜ ๊ณ ์œ„์ง๊ธ‰, ๊ธฐ์กด ์ „์ž์ •๋ถ€ ์—ญ๋Ÿ‰, ์ธ๊ตฌ๋ฐ€๋„๊ฐ€ ๋†’์„์ˆ˜๋ก ๊ณต๊ณต ์•ฑ์ด ๋‚ฎ์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์œผ๋กœ ๋“œ๋Ÿฌ๋‚ฌ๋‹ค. ํ•œํŽธ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ๊ฒฐ์ • ์š”์ธ์— ๋Œ€ํ•œ ์ˆœ์„œ ๋กœ์ง€์Šคํ‹ฑ ํšŒ๊ท€๋ถ„์„ ๊ฒฐ๊ณผ์— ์˜ํ•˜๋ฉด ๋‹ค์Œ๊ณผ ๊ฐ™์ด ๋ถ„์„๋˜์—ˆ๋‹ค. ์šฐ์„  ์ •๋ณด ๋ฐ ๊ธฐ์ˆ  ์š”์ธ์— ๊ด€ํ•˜์—ฌ, ์ •๋ณด ์šฉ๋Ÿ‰์ด ๋‚ฎ์„์ˆ˜๋ก ๊ณต๊ณต ์•ฑ์ด ๋†’์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์œผ๋กœ ๋„์ถœ๋˜์—ˆ๋‹ค. ์กฐ์ง ์š”์ธ์— ๋Œ€ํ•˜์—ฌ, ์ •๋ณดํ™” ์ธ๋ ฅ์ด ์ฆ๊ฐ€ํ• ์ˆ˜๋ก, ์ง€์—ญ ์ •๋ณดํ™” ๊ด€๋ จ ์ถ”์ง„ ์‚ฌ์—… ์˜ˆ์‚ฐ ๋น„์œจ์ด ์ฆ๊ฐ€ํ• ์ˆ˜๋ก ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ์ด ๋‚ฎ์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์œผ๋กœ ๋“œ๋Ÿฌ๋‚ฌ๋‹ค. ์ œ๋„ ์š”์ธ์— ๊ด€ํ•˜์—ฌ, ๊ธฐ์กด ์ „์ž์ •๋ถ€ ์—ญ๋Ÿ‰์ด ๋†’์„์ˆ˜๋ก ๊ณต๊ณต ์•ฑ์ด ๋†’์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์œผ๋กœ ๋ถ„์„๋˜์—ˆ๋‹ค. ํ™˜๊ฒฝ ์š”์ธ์— ๋Œ€ํ•ด์„œ๋Š” ์œ ์˜๋ฏธํ•œ ๋ณ€์ˆ˜๊ฐ€ ๋„์ถœ๋˜์ง€ ์•Š์•˜๋‹ค. ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์™€ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด ๊ณตํ†ต์ ์œผ๋กœ ์ •๋ณด ์šฉ๋Ÿ‰์ด ๋‚ฎ์„์ˆ˜๋ก, ์ง€์—ญ์ •๋ณดํ™” ์‚ฌ์—… ์˜ˆ์‚ฐ์ด ๋‚ฎ์„์ˆ˜๋ก ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ์ด ๋†’์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์œผ๋กœ ๋ถ„์„๋˜์—ˆ๋‹ค. ๋ฐ˜๋ฉด ๊ณต๊ณต ์•ฑ์˜ ์œ ํ˜•, ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์žฅ์˜ ์ •๋ณดํ™” ๊ด€์‹ฌ๋„, ์ •๋ณดํ™” ์ธ๋ ฅ, ์ •๋ณดํ™” ๊ด€๋ จ ์‚ฌ์—… ๊ฑด์ˆ˜, ์ตœ๊ณ ์ •๋ณด๊ด€๋ฆฌ์ฑ…์ž„์ž์˜ ์ง๊ธ‰, ์ •๋ณดํ™” ๊ด€๋ จ ๋ฒ•๋ฅ ์  ํ˜„ํ™ฉ, ํ™˜๊ฒฝ ์š”์ธ์€ ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์™€ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด ๊ฐ„์— ์„œ๋กœ ๋‹ค๋ฅด๊ฒŒ ์˜ํ–ฅ์„ ๋ฐ›๋Š”๋‹ค๋Š” ๊ฒƒ์„ ํŒŒ์•…ํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ์œ„์™€ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์‹ฌ์ธต์ ์œผ๋กœ ํ•ด์„ํ•˜๊ธฐ ์œ„ํ•ด, ์„œ์šธํŠน๋ณ„์‹œ์ฒญ์˜ ๊ณต๊ณต ์•ฑ ๊ด€๋ฆฌ์ž, ์„œ์šธํŠน๋ณ„์‹œ ๊ธˆ์ฒœ๊ตฌ์ฒญ์˜ ๊ณต๊ณต ์•ฑ ๊ด€๋ฆฌ์ž ๋ฐ ์ œ์ž‘์ž๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์ธํ„ฐ๋ทฐ๋ฅผ ์‹ค์‹œํ•˜์˜€๋‹ค. ์ข…ํ•ฉ์ ์œผ๋กœ ์œ„์—์„œ ๋‚˜ํƒ€๋‚œ ๋ถ„์„ ๊ฒฐ๊ณผ๋ฅผ ๋‹ค์Œ๊ณผ ๊ฐ™์ด ํ•ด์„ํ•˜์˜€๋‹ค. ์šฐ์„  ์ •๋ณด ๋ฐ ๊ธฐ์ˆ  ์š”์ธ์— ๊ด€๋ จํ•˜์—ฌ, ์ „์ˆ˜์กฐ์‚ฌ๋ฅผ ํ†ตํ•ด ํŒŒ์•…๋œ ๊ณต๊ณต ์•ฑ ์ค‘ ์ •๋ณด ์šฉ๋Ÿ‰์ด ํฐ ๋Œ€๋ถ€๋ถ„์˜ ๊ณต๊ณต ์•ฑ์ด ์ฃผ๋กœ ๋‹จ์ˆœํ•˜๊ฒŒ ์ •๋ณด ์ œ๊ณต๋งŒ์„ ์„œ๋น„์Šค ํ•˜๋Š” ๊ฒƒ์œผ๋กœ ๋ฐํ˜€์กŒ๋‹ค. ์ฆ‰ ์‚ฌ์ „์ด๋‚˜ ๋น„๊ต์  ์šฉ๋Ÿ‰์ด ๋ฐฉ๋Œ€ํ•œ ๋™์˜์ƒ ๋ฐ ๋ฏธ๋””์–ด๋ฅผ ์ด์šฉํ•˜๋Š” ๊ณต๊ณต ์•ฑ์˜ ๊ฒฝ์šฐ ์ •๋ณด ์šฉ๋Ÿ‰์€ ๋งค์šฐ ํฌ์ง€๋งŒ ์ƒํ˜ธ์†Œํ†ต์ด๋‚˜ ์—…๋ฌด์ฒ˜๋ฆฌ์™€ ๊ฐ™์€ ๊ณ ๋„ํ™” ๋œ ๋‹จ๊ณ„์˜ ์„œ๋น„์Šค๋ฅผ ์ œ๊ณตํ•˜๊ณ  ์žˆ์ง€ ์•Š์•˜๋‹ค. ์ด๋Ÿฌํ•œ ์ ์€ ๊ณต๊ณต ์•ฑ ๊ตฌ์ถ•๊ณผ์ •์—์„œ ๋ฐฉ๋Œ€ํ•œ ์ •๋ณด ์ œ๊ณต์„ ๋ชฉ์ ์œผ๋กœ ์‚ผ์€ ๋‚˜๋จธ์ง€ ์‹œ๋ฏผ ์ฐธ์—ฌ ๋ฐ ์†Œํ†ต์— ๋Œ€ํ•œ ์ˆ˜์š” ์˜ˆ์ธก์— ๋Œ€ํ•œ ๊ณ ๋ ค๊ฐ€ ๋ถ€์กฑํ–ˆ์Œ์„ ์‹œ์‚ฌํ•œ๋‹ค. ์ •๋ณด ์œ ํ˜•์˜ ๊ฒฝ์šฐ, ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์— ํ•œํ•ด์„œ ์—ฌํ–‰ ๋ฐ ์ง€์—ญ ์ •๋ณด์˜ ๊ณต๊ณต ์•ฑ์ด ๋†’์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์œผ๋กœ ๋“œ๋Ÿฌ๋‚ฌ๋‹ค. ์ด๋Š” ๊ณต๊ณต ์•ฑ ์ œ์ž‘ ๊ธฐ๊ด€์ด ๊ด‘์—ญ๋„์‹œ๋ผ๋Š” ์ ์„ ๊ณ ๋ คํ•ด๋ณด๋ฉด ์šฐ์„ ์ ์œผ๋กœ ์ œ์ž‘์„ ๊ณ ๋ คํ•˜๋Š” ์œ ํ˜•์ด ๊ด€๊ด‘์— ๊ด€ํ•œ ์„œ๋น„์Šค๋ผ๋Š” ์ ์„ ํŒŒ์•…ํ•  ์ˆ˜ ์žˆ๋‹ค. ๊ด€๊ด‘ ๋ช…์†Œ ์†Œ๊ฐœ๋ฅผ ๋น„๋กฏํ•˜์—ฌ, ๋ชจ๋ฐ”์ผ๋งŒ์˜ ํŠน์ˆ˜ ๊ธฐ๋Šฅ์ธ ์œ„์น˜๊ธฐ๋ฐ˜ ์„œ๋น„์Šค๋ฅผ ํ†ตํ•ด ์ด์šฉ์ž ๋งž์ถคํ˜• ์„œ๋น„์Šค๋ฅผ ์ „๋‹ฌํ•˜๊ณ , ์ด์šฉ์ž ๊ฐ„ ์ •๋ณด ๊ณต์œ ๊ฐ€ ์ด๋ฃจ์–ด์ง€๋Š” ์ƒํ˜ธ์†Œํ†ต์ด ์ด๋ฃจ์–ด์งˆ ์ˆ˜ ์žˆ๋‹ค. ๋‘˜์งธ, ์กฐ์ง ์š”์ธ๊ณผ ๊ด€๋ จ๋œ ์š”์ธ๋“ค ์ค‘์—์„œ ์šฐ์„  ์ •๋ณดํ™” ๊ด€์‹ฌ๋„์˜ ๊ฒฝ์šฐ, ํ•ด๋‹น ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ์žฅ์ด ๋ชจ๋ฐ”์ผ์„ ํ†ตํ•œ ์†Œํ†ต์ด๋‚˜ ์‹œ์ • ํ™๋ณด์— ๊ด€์‹ฌ์ด ๋งŽ์„์ˆ˜๋ก ์ง€์—ญ์„ ๋Œ€ํ‘œํ•˜๋Š” ๊ณต๊ณต ์•ฑ ์—ญ์‹œ SNS๋ฅผ ๊ตฌ์ถ•ํ•˜๋Š” ๋“ฑ ์ƒํ˜ธ ์†Œํ†ต ๊ธฐ๋Šฅ์— ์ง‘์ค‘ํ•  ํ™•๋ฅ ์ด ๋†’๋‹ค๋Š” ์ ์„ ์‹œ์‚ฌํ•œ๋‹ค. ์ •๋ณดํ™” ๊ด€๋ จ ์ธ๋ ฅ ๋น„์œจ์˜ ๊ฒฝ์šฐ, ๊ด€๋ จ ์ธ๋ ฅ์ด ๋งŽ๋‹ค๊ณ  ํ•ด์„œ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€์ด ๋†’์€ ๊ฒƒ์€ ์•„๋‹Œ ๊ฒƒ์œผ๋กœ ํŒŒ์•…๋˜์—ˆ๋‹ค. ์ฆ‰ ์ธ๋ ฅ์ด ๋งŽ์„ ๊ฒฝ์šฐ ์—…๋ฌด ๋ถ„๋‹ด์˜ ํšจ์œจ์„ฑ ๋„๋ชจ๋ผ๋Š” ์žฅ์ ๊ณผ ์˜์‚ฌ๊ฒฐ์ • ๊ณผ์ •์—์„œ ์˜๊ฒฌ์ด ์ƒ์ถฉ๋  ๊ฐ€๋Šฅ์„ฑ์ด ์ œ๊ธฐ๋  ์ˆ˜ ์žˆ๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. ์ •๋ณดํ™” ์‚ฌ์—…๊ฑด์ˆ˜์™€ ์˜ˆ์‚ฐ์˜ ๊ฒฝ์šฐ, ๊ฑด์ˆ˜๊ฐ€ ๋งŽ์„์ˆ˜๋ก ๊ณต๊ณต ์•ฑ์ด ๋‚ฎ์€ ์ˆ˜์ค€์— ์†ํ•  ํ™•๋ฅ ์ด ๋†’๊ฒŒ ๋„์ถœ๋˜์—ˆ๋Š”๋ฐ, ์ด๋Š” ๊ณต๊ณต ์•ฑ ๊ตฌ์ถ• ์ดˆ๊ธฐ ๋‹จ๊ณ„์—์„œ ๋Œ€๋ถ€๋ถ„ ํ™ˆํŽ˜์ด์ง€๋ฅผ ๊ธฐ๋ณธ์œผ๋กœ ์„œ๋น„์Šค๊ฐ€ ์ด๋ฃจ์–ด์ง€๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. ์ฆ‰ ์ •๋ณดํ™” ์‚ฌ์—… ๊ฑด์ˆ˜๊ฐ€ ์ฆ๊ฐ€ํ•˜๋”๋ผ๋„, ์ฆ‰์‹œ ๊ณต๊ณต ์•ฑ์ด ๊ตฌ์ถ•๋˜๋Š” ๊ฒƒ์ด ์•„๋‹ˆ๋ผ ๊ธฐ๋ณธ ํ‹€์ด ๋˜๋Š” ํ™ˆํŽ˜์ด์ง€ ์‚ฌ์—…์— ์ง‘์ค‘ํ•˜๊ธฐ ๋•Œ๋ฌธ์ด๋‹ค. ์‚ฌ์—… ๊ณ„์‚ฐ์˜ ๊ฒฝ์šฐ ์•ž์„œ ๋…ผ์˜ํ•œ ๋ฐ”์™€ ๊ฐ™์€ ๋งฅ๋ฝ์œผ๋กœ ๋งŽ์€ ์˜ˆ์‚ฐ์ด ํˆฌ์—ฌ๋œ๋‹ค ํ• ์ง€๋ผ๋„, ํ™ˆํŽ˜์ด์ง€๋‚˜ ์ธ๋ ฅ ์ถฉ์›์— ์šฐ์„ ์ ์œผ๋กœ ํ• ๋‹น๋  ๊ฐ€๋Šฅ์„ฑ์„ ๊ณ ๋ คํ•  ์ˆ˜ ์žˆ๋‹ค. ์…‹์งธ, ์ œ๋„ ์š”์ธ๊ณผ ๊ด€๋ จํ•˜์—ฌ, ์ตœ๊ณ ์ •๋ณด๊ด€๋ฆฌ์ฑ…์ž„์ž์˜ ์ง๊ธ‰์ด ๋†’์„์ˆ˜๋ก ๋‚ฎ์€ ์ˆ˜์ค€์˜ ๊ณต๊ณต ์•ฑ์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์€, ๋น„๊ต์  ์ Š์€ ์„ธ๋Œ€๊ฐ€ ์ฃผ๋ฅผ ์ด๋ฃจ๋Š” ์ง๊ธ‰์—์„œ SNS๋ฅผ ํ†ตํ•œ ์‹œ๋ฏผ ์†Œํ†ต ๋ฐ ์ฐธ์—ฌ๋ฅผ ์ฆ์ง„์‹œํ‚ค๊ณ  ์žˆ์Œ์„ ํŒŒ์•…ํ•  ์ˆ˜ ์žˆ๋‹ค. ์ •๋ณดํ™” ๊ด€๋ จ ๋ฒ•๋ น ๋ฐ ์ œ๋„์  ์‚ฌ์•ˆ๋“ค์ด ๋งŽ์„์ˆ˜๋ก ๋†’์€ ์ˆ˜์ค€์˜ ๊ณต๊ณต ์•ฑ์— ์†ํ•  ํ™•๋ฅ ์ด ํฐ ๊ฒƒ์€, ์ƒ์œ„ ๊ธฐ๊ด€์—์„œ ์ฃผ๊ธฐ์ ์œผ๋กœ ๊ณต๊ณต ์•ฑ ์„œ๋น„์Šค์— ๋Œ€ํ•œ ์ง€์นจ ์‚ฌํ•ญ์ด ๋‚ด๋ ค์˜ค๊ณ  ์ด์— ๋”ฐ๋ผ ๊ณต๊ณต ์•ฑ์— ๋Œ€ํ•œ ์ง‘์ค‘์ด ์ด๋ฃจ์–ด์ง€๊ณ  ์žˆ๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„ํ•  ์ˆ˜ ์žˆ๋‹ค. ๊ธฐ์กด ์ •๋ณดํ™” ์—ญ๋Ÿ‰์˜ ๊ฒฝ์šฐ, ๋†’์€ ์—ญ๋Ÿ‰์„ ๋‚˜ํƒ€๋ƒˆ๋˜ ๊ธฐ๊ด€์˜ ๊ฒฝ์šฐ ์ง€์†์ ์œผ๋กœ ํ™ˆํŽ˜์ด์ง€์˜ ๊ธฐ๋Šฅ์— ์ง‘์ค‘ํ•˜๊ฑฐ๋‚˜, ๋‚˜์•„๊ฐ€ ๋ชจ๋ฐ”์ผ ๊ธฐ๋Šฅ์— ์‹ ๊ฒฝ์„ ์“ฐ๋Š” ๊ฒฝ์šฐ๋กœ์จ ๋‘ ๊ฐ€์ง€ ๋ฉด์„ ๋ชจ๋‘ ๊ณ ๋ คํ•  ์ˆ˜ ์žˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์™€ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ์„ ์ „์ˆ˜์กฐ์‚ฌ ํ•จ์œผ๋กœ์จ ๊ณต๊ณต ์•ฑ ํ˜„ํ™ฉ ๋ฐ ์ˆ˜์ค€์„ ํŒŒ์•…ํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ์ด๋Š” ๊ณต๊ณต ์•ฑ ์‚ฌ๋ก€์กฐ์‚ฌ ๋˜๋Š” ์œ ํ˜• ๊ตฌ๋ถ„์ด ์ฃผ๋ฅผ ์ด๋ฃจ์—ˆ๋˜ ์—ฐ๊ตฌ์˜ ํ•œ๊ณ„๋ฅผ ๊ทน๋ณตํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋˜ํ•œ ๊ณต๊ณต ์•ฑ ๊ฒฐ์ • ์š”์ธ์„ ์‹ค์ฆ์ ์œผ๋กœ ๋ถ„์„ํ•จ์œผ๋กœ์จ ์ผ๋ฐ˜ํ™” ๋„์ถœ์— ๊ธฐ์—ฌํ•  ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๋”๋ถˆ์–ด ๊ฒฐ์ • ์š”์ธ์„ ์‹ค์ฆ์ ์œผ๋กœ ํŒŒ์•…ํ•จ์œผ๋กœ์จ ์ดํ›„ ๋”์šฑ ํ™œ๋ฐœํ•ด์งˆ ๊ณต๊ณต ์•ฑ ์ œ์ž‘์— ์•ž์„œ ์ •์ฑ…์  ์‹œ์‚ฌ์ ์„ ์ œ๊ณตํ•  ์ˆ˜ ์žˆ์„ ๊ฒƒ์œผ๋กœ ๊ธฐ๋Œ€๋œ๋‹ค.์ œ1์žฅ ์„œ๋ก  1 ์ œ1์ ˆ ์—ฐ๊ตฌ์˜ ๋ฐฐ๊ฒฝ๊ณผ ๋ชฉ์  1 ์ œ2์ ˆ ์—ฐ๊ตฌ์˜ ๋Œ€์ƒ๊ณผ ๋ฐฉ๋ฒ• 2 ์ œ2์žฅ ์ด๋ก ์  ๋ฐฐ๊ฒฝ ๋ฐ ์„ ํ–‰์—ฐ๊ตฌ ๊ฒ€ํ†  4 ์ œ1์ ˆ ์ „์ž์ •๋ถ€์—์„œ ๋ชจ๋ฐ”์ผ ์ •๋ถ€๋กœ์˜ ์ดํ–‰ 4 1. ๋ชจ๋ฐ”์ผ ์ •๋ถ€์˜ ๋“ฑ์žฅ ๋ฐฐ๊ฒฝ 4 2. ๋ฌด์„ ์ธํ„ฐ๋„ท ๊ธฐ๋ฐ˜์˜ ๋ชจ๋ฐ”์ผ ์ •๋ถ€ 8 3. ๊ณต๊ณต ์•ฑ 11 ์ œ2์ ˆ ์ •๋ณด์‹œ์Šคํ…œ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ์ธก์ •๊ณผ ๊ฒฐ์ •์š”์ธ์— ๊ด€ํ•œ ๋…ผ์˜ 13 1. ์ •๋ณด๊ธฐ์ˆ  ์„ฑ์ˆ™๋„ ๋ฐ ๋ฐœ์ „๋‹จ๊ณ„์— ๊ด€ํ•œ ๋…ผ์˜ 13 2. ์ „์ž์ •๋ถ€ ์„œ๋น„์Šค์˜ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ์ธก์ • ๋ฐ ๋ฐœ์ „๋‹จ๊ณ„์— ๊ด€ํ•œ ๋…ผ์˜ 15 3. ์ „์ž์ •๋ถ€ ์„œ๋น„์Šค์˜ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ๊ฒฐ์ •์š”์ธ์— ๊ด€ํ•œ ๋…ผ์˜ 19 ์ œ3์ ˆ ๊ณต๊ณต ์Šค๋งˆํŠธํฐ ์• ํ”Œ๋ฆฌ์ผ€์ด์…˜์˜ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ๋ฐ ๊ฒฐ์ •์š”์ธ์— ๊ด€ํ•œ ๋…ผ์˜ 22 1. ๊ณต๊ณต ๋ชจ๋ฐ”์ผ ์•ฑ์— ๊ด€ํ•œ ์„ ํ–‰์—ฐ๊ตฌ ๊ฒ€ํ†  22 2. ๊ณต๊ณต ๋ชจ๋ฐ”์ผ ์•ฑ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ๊ฒฐ์ •์š”์ธ์— ๊ด€ํ•œ ์„ ํ–‰์—ฐ๊ตฌ ๊ฒ€ํ†  26 3. ์„ ํ–‰์—ฐ๊ตฌ์— ๋Œ€ํ•œ ๋น„ํŒ์  ๊ฒ€ํ†  29 ์ œ3์žฅ ์—ฐ๊ตฌ ์„ค๊ณ„ 31 ์ œ1์ ˆ ๊ด‘์—ญ ๋ฐ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ „์ˆ˜์กฐ์‚ฌ ๋ฐ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ์ธก์ • 31 1. ๊ด‘์—ญ ๋ฐ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ „์ˆ˜์กฐ์‚ฌ์˜ ๋ชฉ์  31 2. ์ฃผ์š” ์กฐ์‚ฌ ํ•ญ๋ชฉ ๋ฐ ์ˆ˜์ค€ ์ธก์ • ๋ชจํ˜• 31 3. ์ „์ˆ˜์กฐ์‚ฌ์˜ ๋Œ€์ƒ๊ณผ ๋ฐฉ๋ฒ• ๋ฐ ์ ˆ์ฐจ 32 ์ œ2์ ˆ ๊ณต๊ณต ์•ฑ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ๊ฒฐ์ • ์š”์ธ ๋ถ„์„ 33 1. ์—ฐ๊ตฌ์˜ ๊ฐ€์„ค๊ณผ ๋ชจํ˜• 33 1) ์—ฐ๊ตฌ์˜ ๊ฐ€์„ค 33 2) ์—ฐ๊ตฌ์˜ ๋ถ„์„ํ‹€ 38 ์ œ3์ ˆ ๋ณ€์ˆ˜์˜ ์ธก์ • 38 1. ์ข…์† ๋ณ€์ˆ˜ : ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€ 38 1) 1๋‹จ๊ณ„ : ๋‹จ์ˆœ์ œ์‹œ 38 2) 2๋‹จ๊ณ„ : ๋ณตํ•ฉ์ œ์‹œ 38 3) 3๋‹จ๊ณ„ : ๋‹จ์ˆœ์ƒํ˜ธ์ž‘์šฉ 38 4) 4๋‹จ๊ณ„ : ๋ณตํ•ฉ์ƒํ˜ธ์ž‘์šฉ 39 5) 5๋‹จ๊ณ„ : ์—…๋ฌด์ฒ˜๋ฆฌ 39 6) 6๋‹จ๊ณ„ : ํ†ตํ•ฉ 40 2. ๋…๋ฆฝ๋ณ€์ˆ˜ : ๊ณต๊ณต ์•ฑ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ๊ฒฐ์ •์š”์ธ 40 1) ์ •๋ณดยท๊ธฐ์ˆ  ์š”์ธ 40 2) ์กฐ์ง ์š”์ธ 41 3) ์ œ๋„ ์š”์ธ 41 4) ํ™˜๊ฒฝ ์š”์ธ 42 ์ œ4์ ˆ ์ž๋ฃŒ ์ˆ˜์ง‘ ๋ฐ ๋ถ„์„ ๋ฐฉ๋ฒ• 44 1. ๋ถ„์„ ๋Œ€์ƒ 44 2. ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€ ๊ฒฐ์ •์š”์ธ ๋ถ„์„๋ฐฉ๋ฒ• 45 ์ œ4์žฅ ๋ถ„์„๊ฒฐ๊ณผ 46 ์ œ1์ ˆ ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ๊ตฌ์ถ• ํ˜„ํ™ฉ 46 1. ๊ด‘์—ญ ๋ฐ ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด ๋ณ„ ๊ณต๊ณต ์•ฑ ์ œ๊ณต ํ˜„ํ™ฉ 46 2. ๊ณต๊ณต ์•ฑ ์นดํ…Œ๊ณ ๋ฆฌ์— ๋”ฐ๋ฅธ ๊ณต๊ณต ์•ฑ ์ œ๊ณต ํ˜„ํ™ฉ 47 3. ๋‹ค์šด๋กœ๋“œ ๊ฑด์ˆ˜์— ๋”ฐ๋ฅธ ๊ณต๊ณต ์•ฑ ์ œ๊ณต ํ˜„ํ™ฉ 49 ์ œ2์ ˆ ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€ ๊ฒฐ์ •์š”์ธ์— ๋Œ€ํ•œ ๋ถ„์„ 50 1. ๊ธฐ์ดˆํ†ต๊ณ„๋ถ„์„ 50 1) ์ข…์†๋ณ€์ˆ˜ : ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์„ฑ์ˆ™๋„ ์ˆ˜์ค€ ์ธก์ • ๊ฒฐ๊ณผ 50 2) ๋…๋ฆฝ๋ณ€์ˆ˜ 53 2. ์ˆœ์„œ ๋กœ์ง€์Šคํ‹ฑ ํšŒ๊ท€๋ถ„์„ ๊ฒฐ๊ณผ 62 1) ๊ด‘์—ญ์ž์น˜๋‹จ์ฒด์˜ ์ˆœ์„œ ๋กœ์ง€์Šคํ‹ฑ ํšŒ๊ท€๋ถ„์„ ๊ฒฐ๊ณผ 63 2) ๊ธฐ์ดˆ์ž์น˜๋‹จ์ฒด์˜ ์ˆœ์„œ ๋กœ์ง€์Šคํ‹ฑ ํšŒ๊ท€๋ถ„์„ ๊ฒฐ๊ณผ 66 ์ œ3์ ˆ ์ง€๋ฐฉ์ž์น˜๋‹จ์ฒด์˜ ๊ณต๊ณต ์•ฑ ์ˆ˜์ค€ ๊ฒฐ์ •์š”์ธ์— ๋Œ€ํ•œ ๋ถ„์„ : ๋‹ด๋‹น ๊ณต๋ฌด์› ์ธํ„ฐ๋ทฐ๋ฅผ ์ค‘์‹ฌ์œผ๋กœ 70 1. ์ •๋ณดยท๊ธฐ์ˆ  ์š”์ธ 70 2. ์กฐ์ง ์š”์ธ 73 3. ์ œ๋„ ์š”์ธ 77 ์ œ5์žฅ ๊ฒฐ๋ก  80 ์ œ1์ ˆ ์—ฐ๊ตฌ๊ฒฐ๊ณผ์˜ ์š”์•ฝ 80 ์ œ2์ ˆ ์—ฐ๊ตฌ์˜ ์˜์˜ 82 ์ œ3์ ˆ ์—ฐ๊ตฌ์˜ ํ•œ๊ณ„ 83 ์ฐธ๊ณ ๋ฌธํ—Œ 85Maste

    Clinical observation of histocytosis in childhood : with special reference to chemotherapy

    No full text
    ์˜ํ•™๊ณผ/์„์‚ฌ[ํ•œ๊ธ€] Histiocytosis๋Š” ๊ณจ์ˆ˜์˜ ๋‹จํ•ต๊ตฌ์—์„œ ์œ ๋ž˜ํ•œ ์กฐ์ง๊ตฌ๊ฐ€ ์ฆ์‹ํ•˜๋Š” ์งˆํ™˜์œผ๋กœ eosinophilic granuloma, Hand-Schuller-Christan disease, Letterer-Siwe disease, histiocytic medullary reticulosis, histiocytic lymphoms, monocytic leukemia ์ด๊ด„ํ•˜์—ฌ์•ผ ํ•˜๋‚˜ ์ผ๋ฐ˜์ ์œผ ๋กœ histiocytic Iymphoma์™€ monocytic leukemia๋ฅผ ์ œ์™ธํ•œ 4๊ฐ€์ง€์˜ ์งˆํ™˜์„ ์ง€์นญํ•œ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๊ฐ์ข… histiocytosis์˜ ์ž„์ƒ์  ํŠน์ง•, ์น˜๋ฃŒ ๋ฐ ์˜ˆํ›„๋ฅผ ๋น„๊ตํ•˜๊ณ  ๋ถ„์„ ๊ฒ€ํ† ํ•จ์œผ๋กœ์จ ์ง„๋‹จ๊ณผ ์น˜๋ฃŒ์— ๋„์›€์ด ๋˜๊ณ ์žํ•˜๋Š” ๋ชฉ์ ์œผ๋กœ ์‹œํ–‰๋˜์—ˆ๋‹ค. ๊ด€์ฐฐ๋Œ€์ƒ์€ 1975๋…„ 1์›”๋ถ€ํ„ฐ 1981๋…„ 12์›”๊นŒ์ง€ ์—ฐ์„ธ ์˜๋Œ€ ๋ถ€์† ์„ธ๋ธŒ๋ž€์Šค ๋ณ‘์› ๋ฐ ์—ฐ์„ธ ์•”์„ผํƒ€์—์„œ histiocytosis๋กœ ์ง„๋‹จ ๋ฐ ์น˜๋ฃŒ๋ฅผ ๋ฐ›์€ ํ™˜์ž์ค‘ 15์„ธ ์ดํ•˜์˜ ์†Œ์•„์—ฐ๋ น ํ™˜์ž 34์˜ˆ๋ฅผ ๋Œ€์ƒ์œผ๋กœ ํ•˜์˜€์œผ๋ฉฐ ๊ฐ ์งˆํ™˜๋ณ„ ์ž„์ƒ์  ํŠน์ง•์„ ์กฐ์‚ฌํ•˜๋Š” ํ•œํŽธ. ์ถ”์ ๊ด€์ฐฐ์ด ๊ฐ€๋Šฅํ•˜์˜€๋˜ 2 6์˜ˆ์— ๋Œ€ํ•˜์—ฌ ์น˜๋ฃŒ๊ฒฐ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์—ฌ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์–ป์—ˆ๋‹ค. ๊ฐ ์งˆํ™˜๋ณ„ ๋นˆ๋„๋Š” Hand-Schuller-Christian disease์™€ Letterer-Siwe disease๊ฐ€ ๊ฐ๊ฐ 11์˜ˆ๋กœ ๊ฐ€์žฅ ๋งŽ์•˜๊ณ , eosinophilic granuloma๊ฐ€ 7์˜ˆ, histiocytic medullary reticulosis๊ฐ€ 5์˜ˆ ์˜€์œผ๋ฉฐ, ๋ฐœ๋ณ‘์—ฐ๋ น์€ histiocytic medullary reticulosis์™€ eosinophilic granuloma๋Š” ์ฃผ๋กœ ์œ ๋…„๊ธฐ์— ๋ฐœ๋ณ‘ํ•˜๋Š” ๋ฐ˜๋ฉด์— Lettermer-Swice disease๋Š” ์ฃผ๋กœ 1์„ธ ๋ฏธ๋งŒ์—์„œ, Hand-Schuller-Christian disease๋Š” ๊ทธ ์ค‘๊ฐ„ ์—ฐ๋ น์ธต์—์„œ ๋ฐœ๋ณ‘ํ•˜์˜€๋‹ค. ์ž„์ƒ์ฆ์ƒ์€ eosinophilic granuloma์™€ Hand-Schu11er-Christitan disease๋Š” ์ฃผ๋กœ ๊ณจ๋ณ‘๋ณ€์ด์—ˆ๋Š”๋ฐ ๋น„ํ•˜๋ฉด Letterer-Siwe disease์™€ histiocyic medullary reticulosis์—์„œ๋Š” ๋ฐ˜๋ณต๋˜๋Š” ๊ณ ์—ด, ๋ณต๋ถ€์žฅ๊ธฐ์˜ ์ข…๋Œ€, ์ถœํ˜ˆ์„ฑ ๊ฒฝํ–ฅ ๋ฐ ์ฒด์ค‘๊ฐ์†Œ๋“ฑ์ด ์ค‘์š” ์ฆ์ƒ์ด์—ˆ์œผ๋ฉฐ ํŠนํžˆ Le tterer-Siwe disease์—์„œ๋Š” ํ”ผ๋ถ€๋ฐœ์ง„๊ณผ ํ™”๋†์„ฑ์ด๋ฃจ๊ฐ€ ํŠน์ง•์ ์ด์—ˆ๊ณ , histiocytic medullary reticulosis์—์„œ๋Š” ๊ฑฐ๋Œ€ํ•œ ์ž„ํŒŒ์„  ์ข…๋Œ€์™€ ์ถœํ˜ˆ์„ฑ ๊ฒฝํ–ฅ์ด ํŠน์ง•์ ์ด์—ˆ๋‹ค. ํ์นจ์œค์€ Letterer-Siwe disease์™€ histiocytic medullary reticulosis์˜ ๊ฐ 3์˜ˆ์—์„œ ๊ด€์ฐฐ๋˜์—ˆ๋‹ค. ๊ณจ๋ณ‘๋ณ€์˜ ํ˜ธ๋ฐœ๋ถ€์œ„๋Š” eosinophilic granuloma์˜ ๊ฒฝ์šฐ์—๋Š” ์ฒ™์ถ”๊ณจ. Hand-Schaller- Christian disease์˜ ๊ฒฝ์šฐ์—๋Š” ๋‘๊ฐœ๊ณจ์ด์—ˆ๋‹ค. ๊ฒ€์‚ฌ์†Œ๊ฒฌ์ƒ Letterer-Siwe disease์™€ histiocytic medullary reticulosis์˜ ๋Œ€๋ถ€๋ถ„์—์†Œ ์กฐํ˜ˆ๊ธฐ๋Šฅ ์ด์ƒ๊ณผ ๊ฐ„๊ธฐ๋Šฅ ์ด์ƒ ์†Œ๊ฒฌ์„ ๋ณด์˜€๋‹ค. ์น˜๋ฃŒ๊ฒฐ๊ณผ๋ฅผ ๋ณด๋ฉด eosinophilic granuloma์™€ Hand-Schu11er -Christian diseaae์—์„œ๋Š” ์ˆ˜์ˆ ์š”๋ฒ• ๋‹จ๋… ํ˜น์€ ์ˆ˜์ˆ ์š”๋ฒ•๊ณผ ๋ฐฉ์‚ฌ์„  ์น˜๋ฃŒํ›„ ์ถ”์ ๋˜์—ˆ๋˜ 13์˜ˆ์ค‘ 6์˜ˆ๋Š” ์™„์ „ํžˆ ํšŒ๋ณต๋˜์—ˆ๊ณ  1์˜ˆ๋งŒ์ด ์‚ฌ๋งํ•˜์˜€์œผ๋ฉฐ ๋‚˜๋จธ์ง€ 6์˜ˆ๋Š” ๊ณ„์†์ ์ธ ์ถ”์ ๊ด€์ฐฐ์ด ๋ถˆ๊ฐ€๋Šฅํ•˜์˜€๋‹ค. ์ด์— ๋ฐ˜ํ•˜์—ฌ Letterer-Siwe disease์™€ histiocytic medullary reticulosis์˜ ๊ฒฝ์šฐ๋Š” ๋ชจ๋‘ ํ•ญ์•”์ œ ์น˜๋ฃŒ๋ฅผ ํ•˜์˜€์œผ๋‚˜ ์น˜๋ฃŒ๊ฒฐ๊ณผ๊ฐ€ ๋งค์šฐ ๋ถˆ๋Ÿ‰ํ•˜์—ฌ ์ถ”์ ๋œ 15์˜ˆ์ค‘ Letterer-Siwe diseaae์™€ histiocytic medullary reticulosis์˜ ๊ฐ 2์˜ˆ์—์„œ ์ผ์‹œ์ ํ˜ธ์ „์„ ๋ณด์˜€์œผ๋‚˜ ๊ฒฐ๊ตญ ๋ชจ๋‘ ์‚ฌ๋งํ•˜์˜€๊ณ  ํ˜„์žฌ๊นŒ์ง€ ๋ถˆ๊ณผํ•˜์˜€๋‹ค. ํ™˜์ž์˜ ์น˜๋ฃŒ ๊ฒฐ๊ณผ๋Š” ๋ฐœ๋ น์—ฐ๋ น์ด ๋‚ฎ์„์ˆ˜๋ก ๋ถˆ๋Ÿ‰ํ•˜์˜€์œผ๋ฉฐ(Lettere-Siwe disease :median ์ƒ์กด๊ธฐ๊ฐ„ 1.5๊ฐœ์›” + ) ํ”ผ๋ถ€, ๊ฐ„. ๋น„์žฅ, ํ˜ˆ์†ŒํŒ๊ฐ์†Œ๋‚˜ ์ถœํ˜ˆ์„ฑ๊ฒฝํ–ฅ ๋ฐ ๊ท€์นจ๋ฒ”์ด ์žˆ๋Š” ๊ฒฝ์šฐ ์— ๋ถˆ๋Ÿ‰ํ•˜์˜€๊ณ  (P<0.05), ํŠนํžˆ ํ”ผ๋ถ€, ๋น„์žฅ, ํ˜ˆ์†ŒํŒ๊ฐ์†Œ๋‚˜ ์ถœํ˜ˆ์„ฑ๊ฒฝํ–ฅ ๋ฐ‘ ๊ท€์˜ ์นจ๋ฒ•์ด ์žˆ์„๋•Œ ๋”์šฑ ๋ถˆ๋Ÿ‰ํ•˜์˜€๋‹ค (p< 0.01). Clinical Observation of Histiocytosie in Childhood-With Special Reference to Chemetherapy- Hee Jung Chung Department of Medical Science The Graduate School, Yonsei University (Directed by professor Byung Soo Klm, M.D.) A study on Histiocytosis in childhood was conducted based on 34 cases diagnosed at the Department of Pediatrics of the Severance Hospital and Yonsei Cancer Center from January 1975 to December 1981. The results may be summarized as follows : 1. Among histiocytosis HSC and LSD were each present in eleven cases, E-G in seven and HMR in five cases. HMR and E-G usually occured in older children and adolescents, while LSD occured in children under one year and HSC between the ages of the former and the latter. 2. The major clinical symptom of I-G and HSC was bone involvement, while those of LSD and HHR were recurring high fever, visceral organ involvement, weigh loss and bleeding tendency. In addition, skin rash and purulent otorrhea were seen especially in LSD, and Large Iymphadenopathy and bleeding tendency were observed in HHR. 3. The most common states of bone Involvement were vertebrae in E-G and the skull in HSC. 4. In the laboratory findings, llver dysfunction and hematopoietic disorder were seen in LSD and HHR. Lung infiltration was seen In three cases each of LSD and HMR. 5. I-G and HSC were treated either by surgery or by surgery In conjunotion with radiation therapy. Among the 18 cases, 13 ceases were fellowed up. In six cases the patients recovered, the observers lst track of six others during the courae of follow up and the remaining one died. Based upon their poor prognosis, the LSD and HMR cases were treated with anticancer drugs, mainly with prednisone and vinblastin. Among the 16 cases, eleven were fellowed up, but only one survives at present. 6. The Prognosis was Poorer the younger the patient was at the onset of the disease, and the greater the incidence and the severity of visceral organ involvement. 7. Skin, liver, spleen, thrombocytopenia &/or hemorhagic skin lesion and ear Involvement were also correlated with poor prognosis (P < 0.05). [์˜๋ฌธ] A study on Histiocytosis in childhood was conducted based on 34 cases diagnosed at the Department of Pediatrics of the Severance Hospital and Yonsei Cancer Center from January 1975 to December 1981. The results may be summarized as follows : 1. Among histiocytosis HSC and LSD were each present in eleven cases, E-G in seven and HMR in five cases. HMR and E-G usually occured in older children and adolescents, while LSD occured in children under one year and HSC between the ages of the former and the latter. 2. The major clinical symptom of I-G and HSC was bone involvement, while those of LSD and HHR were recurring high fever, visceral organ involvement, weigh loss and bleeding tendency. In addition, skin rash and purulent otorrhea were seen especially in LSD, and Large Iymphadenopathy and bleeding tendency were observed in HHR. 3. The most common states of bone Involvement were vertebrae in E-G and the skull in HSC. 4. In the laboratory findings, llver dysfunction and hematopoietic disorder were seen in LSD and HHR. Lung infiltration was seen In three cases each of LSD and HMR. 5. I-G and HSC were treated either by surgery or by surgery In conjunotion with radiation therapy. Among the 18 cases, 13 ceases were fellowed up. In six cases the patients recovered, the observers lst track of six others during the courae of follow up and the remaining one died. Based upon their poor prognosis, the LSD and HMR cases were treated with anticancer drugs, mainly with prednisone and vinblastin. Among the 16 cases, eleven were fellowed up, but only one survives at present. 6. The Prognosis was Poorer the younger the patient was at the onset of the disease, and the greater the incidence and the severity of visceral organ involvement. 7. Skin, liver, spleen, thrombocytopenia &/or hemorhagic skin lesion and ear Involvement were also correlated with poor prognosis (P < 0.05).restrictio

    Effects of vanadate on the contractility of vascular smooth muscle

    No full text
    ์˜ํ•™๊ณผ/๋ฐ•์‚ฌ[ํ•œ๊ธ€] ํฌ์œ ๋™๋ฌผ์˜ ์ƒ์ฒด์กฐ์ง์— ๋ฏธ๋Ÿ‰์œผ๋กœ ๋ถ„ํฌ๋˜์–ด ์žˆ๋Š” vanadate์˜ ์ฃผ ์ž‘์šฉ์€ Na**+_K**+ -ATPase๋ฅผ ์–ต์ œํ•˜๋Š” ๊ฒƒ์ด๋ฉฐ ์ด๋Š” ์‹ฌ์žฅ๊ทผ, ๊ณจ๊ฒฉ๊ทผ ๋ฐ ํ‰ํ™œ๊ทผ์—์„œ ๊ฐ•๋ ฅํ•œ ์ˆ˜์ถ•์ž‘์šฉ์„ ๋‚˜ํƒ€๋‚ธ๋‹ค. ํŠนํžˆ ์ด vanadate๋ฅผ ์ƒ์ฒด๋‚ด์— ํˆฌ์—ฌ์‹œ ํ˜ˆ๊ด€๊ณ„์— ์ž‘์šฉํ•˜์—ฌ ๋™๋งฅ์•• ๋ฐ ๋ง์ดˆ์ €ํ•ญ์„ ์ฆ๊ฐ€์‹œํ‚ค๊ณ , ๊ด€์ƒํ˜ˆ๋ฅ˜๋Ÿ‰, ๋‚ด์žฅํ˜ˆ๋ฅ˜๋Ÿ‰ ๋ฐ ์‹ ์žฅํ˜ˆ๋ฅ˜๋Ÿ‰์„ ๊ฐ์†Œ์‹œํ‚จ๋‹ค. ๋˜ vanadate๋Š” ๋ถ„๋ฆฌ๋œ ํ˜ˆ๊ด€ ์ ˆํŽธ ์ฆ‰ ๋‡Œ์ €๋™๋งฅ, ์žฅ๊ฐ„๋ง‰๋™๋งฅ, ๋Œ€๋™๋งฅ์„ ์ˆ˜์ถ•์‹œํ‚จ๋‹ค. ๊ทผ์ž์—๋Š” ํ˜ˆ๊ด€์˜ ๊ธด์žฅ๋„๋Š” ํ˜ˆ๊ด€์˜ ๋‚ดํผ์„ธํฌ์—์„œ ์œ ๋ฆฌ๋˜๋Š” endothelium-derived relaxing factor(EDRF)์™€ endothelium-derived contracting factor(EDCF)์— ์˜ํ•˜์—ฌ ์กฐ์ ˆ๋œ๋‹ค๋Š” ๊ฒƒ์ด ๋ณด๊ณ ๋˜์—ˆ๋‹ค. ๋”ฐ๋ผ์„œ ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ฐ€ํ† ์—์„œ ์ ์ถœํ•œ ๋Œ€๋™๋งฅ์ ˆํŽธ์—์„œ ๋‚ดํ”ผ์„ธํฌ๊ฐ€ ์กด ์žฌํ•  ๋•Œ์™€ ์ œ๊ฑฐ๋˜์—ˆ์„ ๋•Œ ํ˜ˆ๊ด€์ˆ˜์ถ•์— ๋ฏธ์น˜๋Š” vanadate์˜ ์˜ํ–ฅ์„ ๊ด€์ฐฐํ•˜๊ณ  ๊ทธ ๊ธฐ์ „์˜ ์ผ๋ถ€๋ฅผ ๋ฐํžˆ๊ณ ์ž ํ•˜์˜€๋‹ค. ๊ฐ€ํ† ๋ฅผ ๋‘๋ถ€๊ฐ•ํƒ€ํ•˜์—ฌ ํฌ์ƒ์‹œ์ผœ ํ•˜ํ–‰์„ฑ ํ‰๋ถ€๋Œ€๋™๋งฅ์„ ์ ์ถœํ•˜์—ฌ ํ˜ผํ•ฉ๊ธฐ์ฒด๋กœ ํฌํ™”์‹œํ‚จ Krebs ์šฉ์•ก๋‚ด์—์„œ ์ฃผ์œ„์กฐ์ง์„ ์ œ๊ฑฐํ•˜๊ณ  2mm์˜ ํญ์œผ๋กœ ์ž˜๋ผ ๋Œ€๋™๋งฅํ™˜์„ ๋งŒ๋“ค์–ด muscle chamber์— ๊ณ ์ •ํ•˜์˜€๋‹ค. ํ˜ˆ๊ด€์˜ ์ˆ˜์ถ•์€ ํ˜ˆ๊ด€์ˆ˜์ถ•์ œ๋กœ ์œ ๋„์‹œํ‚ค๊ณ  ๊ทธ ์žฅ๋ ฅ์€ Polygraph์— ๊ธฐ๋กํ•˜์˜€๊ณ , ์ˆ˜์ถ•๋œ ํ˜ˆ๊ด€์ด vanadate ์ฒจ๊ฐ€๋กœ ๋‚˜ํƒ€๋‚˜๋Š” ๋ณ€ํ™”๋ฅผ ๊ด€์ฐฐํ•˜์˜€์œผ๋ฉฐ, ๋˜ํ•œ ์—ฌ๋Ÿฌ๊ฐ€์ง€ ๋‚ดํ”ผ์„ธํฌ์˜์กด ์ด์™„์–ต์ œ์ œ๊ฐ€ vanadate๋กœ ์œ ๋„๋œ ํ˜ˆ๊ด€ ์žฅ๋ ฅ์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ๋„ ๊ด€์ฐฐํ•˜์—ฌ ๋‹ค์Œ๊ณผ ๊ฐ™์€ ๊ฒฐ๊ณผ๋ฅผ ์–ป์—ˆ๋‹ค. 1. Vanadate๋Š” norepinephrine (NE)์œผ๋กœ ์œ ๋„๋œ ํ˜ˆ๊ด€์ˆ˜์ถ•์„ ๋‚ดํ”ผ์„ธํฌ ์กด์žฌ (EC**+) ํ˜ˆ๊ด€์€ ์ดํ™˜์‹œํ‚ค๊ณ , ๋‚ดํ”ผ์„ธํฌ๊ฐ€ ์ œ๊ฑฐ๋œ ํ˜ˆ๊ด€ (EC**-)์€ ์ˆ˜์ถ•์‹œํ‚ค๊ฑฐ๋‚˜ ์˜ํ–ฅ์„ ๋ฏธ์น˜์ง€ ์•Š์•˜๋‹ค. ์ด๊ฒƒ์œผ๋กœ vanadate๋Š” acetylcholine(ACh)๊ณผ ์œ ์‚ฌํ•˜๊ฒŒ ๋‚ดํ”ผ์„ธํฌ์˜์กด ํ˜ˆ๊ด€ํ™•์žฅ์ œ๋กœ ์ž‘์šฉ ํ•จ์„ ์•Œ ์ˆ˜ ์žˆ์—ˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ angiotensin โ…ก (All)๋กœ ์œ ๋„๋˜๋Š” ํ˜ˆ๊ด€ ์ˆ˜์ถ•์€ EC**+ ์™€ EC**-์˜ ํ˜ˆ๊ด€์„ ๋ชจ๋‘ ์ด์™„์‹œ์ผฐ์œผ๋ฉฐ, K**+์œผ๋กœ ์œ ๋„๋˜๋Š” ํ˜ˆ๊ด€์ˆ˜์ถ•์€ ๋ชจ๋‘ ์ฆ๊ฐ€์‹œ์ผฐ๋‹ค. 2. Vanadate ์ „์ฒ˜์น˜๋Š” EC**+์˜ ํ˜ˆ๊ด€์—์„œ NE๊ณผ All๋กœ ์œ ๋„๋˜๋Š” ํ˜ˆ๊ด€์ˆ˜์ถ•์„ ๋ชจ๋‘ ์–ต์ œํ•˜์˜€์œผ๋‚˜ K**+์œผ๋กœ ์œ ๋„๋œ ํ˜ˆ๊ด€๊ฒฝ์ถ•์€ ์ฆ๊ฐ€์‹œ์ผฐ๋‹ค. 3. Vanadate๋กœ ์œ ๋„๋œ ํ˜ˆ๊ด€์ด์™„์€ ๋‚ดํ”ผ์„ธํฌ์˜์กด ์ด์™„์–ต์ œ์ œ์ธ methylene blue, hemoglobin, hydroquinone๊ณผ verapamil์— ์˜ํ•ด ์–ต์ œ๋˜์—ˆ๊ณ  quinacrine ๋ฐ indomethacin์— ์˜ํ•ด ์˜ํ–ฅ์„ ๋ฐ›์ง€ ์•Š์•˜๋‹ค. ์ด์ƒ์˜ ์„ฑ์ ์œผ๋กœ ๋ฏธ๋ฃจ์–ด vanadate๋Š” ๋‚ดํ”ผ์„ธํฌ๋กœ๋ถ€ํ„ฐ ํ‘์ข…์˜ ์ด์™„๋ฌผ์งˆ์„ ์œ ๋ฆฌํ•˜์—ฌ ํ˜ˆ๊ด€์ˆ˜์ถ•์„ ์–ต์ œํ•˜๋Š” ๊ฒƒ์œผ๋กœ ์ถ”์ธก๋˜๋ฉฐ, ๊ทธ ๊ธฐ์ „์€ ๋‚ดํ”ผ์„ธํฌ์˜ Ca**++ channel ํ™œ์„ฑํ™”๋กœ EDRF ์œ ๋ฆฌ๋ฅผ ์ฆ๊ฐ€์‹œํ‚ค๊ณ , ์ด EDRF๋Š” ํ˜ˆ๊ด€ํ‰ํ™œ๊ทผ์˜ guanylate cyclase๋ฅผ ํ™œ์„ฑํ™”์‹œ์ผœ ๊ทผ์œก์˜ ์ˆ˜ ์ถ•์„ ์–ต์ œํ•˜๋Š” ๊ฒƒ์œผ๋กœ ์ƒ๊ฐ๋˜๋Š” ๋ฐ”์ด๋‹ค. [์˜๋ฌธ] Vandate is a trace element in animal tissues and has been known to inhibit Na**+ - K**+ - ATPase in various tissues including skeletal and cardiac muscles and smooth muscles. Vanadate shows contractile actions on various types of smooth muscles. Prolonged dietary administration of vanadate has been shown to cause arterial hypertension, increased peripheral resistance, and a marked reduction of coronary, visceral and renal blood flow. In isolated vascular smooth muscle of aortae, application of vanadate caused contraction. These studies have been conducted the preparations of vascular smooth muscles in which endothelial cells were removed. It has been reported that endothelial cell releases relaxing factor(5) (endothelium-derived relaxing factor, EDRF)in response to acetylcholine and a number of other stimuli and also produce vasoconstrictor substances (endotheliumยทderived contracting factor, EDCF). The aim of the present experiments is to elucidate whether vascular responses of isolated rabbit aorta induced by vanadate are endothelium dependent or not. The results obtained were summarized as follows; 1. When endothelium was intact, vanadate induced vascular relaxation of aorta precontracted with norepinephrine. But K**+ induced contraction was augmented by vanadate in the aorta with or without endothelium. Whereas relaxation produced by vanadate precontracted with angiotensin โ…ก was endothelium-independent. 2. Hemoglobin, methylene blue, hydroquinone, and verapamil inhibited vanadate-induced vascular relaxation. But indomethacin and quinacrine had no effect on vanadate induced vascular relaxation. From the above results, it is speculated that vanadate acts on endothelium, modifies the synthesis or release of endothelium-dependent relaxing factor and thus changes the contractile responses to norepinephrine in rabbit aorta.restrictio

    ์ฐฝ์ž‘๋ฌด์šฉ ํ”„๋กœ๊ทธ๋žจ์ด ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์˜ ์‹ฌ๋ฆฌ์  ์š”์†Œ์™€ ์ด๋™์„ฑ์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ

    Get PDF
    ํ•™์œ„๋…ผ๋ฌธ (๋ฐ•์‚ฌ)-- ์„œ์šธ๋Œ€ํ•™๊ต ๋Œ€ํ•™์› : ์‚ฌ๋ฒ”๋Œ€ํ•™ ์ฒด์œก๊ต์œก๊ณผ, 2018. 8. ์ด์šฉํ˜ธ.2002๋…„ ์„ธ๊ณ„ ๋ณด๊ฑด๊ธฐ๊ตฌ(WHO)๊ฐ€ ์žฅ์•  ๋ถ„๋ฅ˜์— ๊ด€ํ•ด Functional, Disability and Health (ICF) ๋ชจ๋ธ์„ ์ œ์•ˆํ•˜๊ณ  ๊ทธ ๋™์•ˆ ๊ฐ„๊ณผ๋˜์–ด ์™”๋˜ ํ™œ๋™(activity), ์ฐธ์—ฌ(participants), ๊ฐœ์ธ(individual) ๋ฐ ํ™˜๊ฒฝ(environment)์˜ ๋งฅ๋ฝ์  ๊ณ ๋ ค๊ฐ€ ๊ฐ•์กฐ๋˜๋ฉด์„œ, ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์„ ๋Œ€์ƒ์œผ๋กœ ํ•œ ์ค‘์žฌ ํ™œ๋™์—๋„ ๋ณ€ํ™”๊ฐ€ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ด์— ๊ด€ํ•ด ์ƒํƒœํ•™์  ์ ‘๊ทผ๋ฒ•๊ณผ ๋™์  ์‹œ์Šคํ…œ ์ด๋ก (Dynamic system theory: DST)๊ณผ ๊ฐ™์€ ์ƒˆ๋กœ์šด ๊ฐœ๋…์„ ์ ์šฉํ•œ ์žฌํ™œ ๋ฐ ์‹ ์ฒดํ™œ๋™์ด ๊ธฐ๋Šฅ, ํ™œ๋™, ์ฐธ์—ฌ ์ฆ์ง„์— ์‹คํšจ์„ฑ์ด ์žˆ๋‹ค๋Š” ์ ์— ์ดˆ์ ์„ ๋‘๊ณ  ์ฃผ๋ชฉ๋ฐ›๊ณ  ์žˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ์˜ ๋ชฉ์ ์€ ์ฐฝ์ž‘๋ฌด์šฉ์„ ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์˜ ์ƒˆ๋กœ์šด ์‹ ์ฒดํ™œ๋™์œผ๋กœ ์ œ์•ˆํ•˜๊ธฐ ์œ„ํ•˜์—ฌ, ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์—๊ฒŒ ์ฐฝ์ž‘๋ฌด์šฉ์„ ์‹ค์‹œํ•˜์—ฌ ์‹ฌ๋ฆฌ์  ์š”์ธ๊ณผ ์ด๋™์„ฑ์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ์„ ๊ฒ€์ฆํ•˜๋Š” ๊ฒƒ์ด๋‹ค. ๋ณธ ์—ฐ๊ตฌ ์ฐธ๊ฐ€์ž๋Š” ๋…๋ฆฝ๋ณดํ–‰์ด ๊ฐ€๋Šฅํ•œ GMFCS Level โ… - โ…ก์— ํ•ด๋‹นํ•˜๋Š” ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ 10๋ช…์œผ๋กœ ํŽธ์˜ํ‘œ์ง‘(convenient sampling)ํ•˜์˜€๋‹ค. ๋‡Œ์„ฑ๋งˆ๋น„ ์œ ํ˜•์€ level โ… ์˜ 3๋ช…์€ ๊ฐ•์งํ˜• ํŽธ๋งˆ๋น„(spastic hemiplegia)์ด๊ณ , ์–‘์ธก๋งˆ๋น„(Diplegia) 7๋ช…์€ level โ…ก์ด๋‹ค. ์ฐธ์กฐ๊ทธ๋ฃน(reference group)์€ ๋น„์žฅ์• ์ธ 314๋ช…์ด๋‹ค. ์ฐธ์กฐ๊ทธ๋ฃน์€ ์‹คํ—˜๊ตฐ๊ณผ ๋™์ผํ•œ ์กฐ๊ฑด์—์„œ ๋ณดํ–‰ ์ธก์ •์„ ์‹ค์‹œํ•˜์˜€๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๋ถ„๋‹น์„œ์šธ๋Œ€ํ•™๊ต ๋ณ‘์› IRB(B-1707-408-302) ์Šน์ธ์„ ๋ฐ›์•˜๋‹ค. ๋ณธ ์—ฐ๊ตฌ ์„ค๊ณ„๋Š” A single-cohort before and after comparison study์ด๋‹ค. ์‹ฌ๋ฆฌ์  ์š”์ธ์€ ํ†ตํ•ฉ์—ฐ๊ตฌ๋ฐฉ๋ฒ•(mixed method)๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ์‹ ์ฒด ๋งŒ์กฑ๋„(Secord & Jourard, 1953)์™€ ์‹ ์ฒด ์กด์ค‘๊ฐ(Mendelson, Andrews, Balfour & Buvholx, 1997)์€ ์„ค๋ฌธ์ง€ ์—ฐ๊ตฌ๋ฅผ ์‹ค์‹œํ•˜์˜€๊ณ , ์ฐฝ์ž‘๋ฌด์šฉ ํ”„๋กœ๊ทธ๋žจ ์ฐธ์—ฌ ๊ฒฝํ—˜์— ๊ด€ํ•œ ํƒ๊ตฌ์— ๊ด€ํ•ด์„œ๋Š” ์‹ฌ์ธต์ธํ„ฐ๋ทฐ๋ฅผ ์‹ค์‹œํ•˜์˜€๋‹ค. ์ด๋™์„ฑ์€ ๋Œ€๋™์ž‘์šด๋™๊ธฐ๋Šฅ๊ณผ ๋ณดํ–‰๊ธฐ๋Šฅ์œผ๋กœ ์ธก์ •ํ•˜์˜€๋‹ค. ๋Œ€๋™์ž‘์šด๋™ ๊ธฐ๋Šฅ์€ GMFM(Gross Motor Functioin Measurement)์˜ D(์„œ๊ธฐ)์˜์—ญ๊ณผ E(๊ฑท๊ธฐ, ๋‹ฌ๋ฆฌ๊ธฐ, ๋„์•ฝ)์˜์—ญ์œผ๋กœ ํ‰๊ฐ€ ํ•˜์˜€๋‹ค. ๋ณดํ–‰ ๋ถ„์„์€ S๋Œ€ํ•™๋ณ‘์› ๋ณดํ–‰ ๋ถ„์„์‹ค(Kestrel digital system (Motion analysis co. CA, USA)์—์„œ ์ง„ํ–‰๋˜์—ˆ๋‹ค. ์—ฐ๊ตฌ ์ฐธ๊ฐ€์ž๋Š” ๋งจ๋ฐœ๋กœ 9m ๋ณดํ–‰๋กœ๋ฅผ ํ‰์†Œ ๋ณดํ–‰ ์†๋„๋กœ 3ํšŒ ์‹ค์‹œํ•˜์˜€๋‹ค. ํ†ต๊ณ„์  ๋ถ„์„์€ SPSS(ver. 23.0)์„ ์‚ฌ์šฉํ•˜์—ฌ ์ธก์ •๋ณ€์ธ์˜ ํ‰๊ท ๊ณผ ํ‘œ์ค€ํŽธ์ฐจ๋ฅผ ์‚ฐ์ถœํ•˜์˜€๊ณ  ์ค‘์žฌ ์ „ใ†ํ›„ ๋น„๊ต๋Š” Wilcoxon signed rank-sum์™€ paired t-test๋ฅผ ์ด์šฉํ•˜์—ฌ ๋ถ„์„ ํ•˜์˜€๋‹ค. ์œ ์˜์ˆ˜์ค€์€ p ์‹ฌ๋ฆฌ์  ์š”์ธ ๋ถ„์„ ๊ฒฐ๊ณผ ์‹ ์ฒด ๋งŒ์กฑ๋„(p=0.005)์™€ ์‹ ์ฒด ์กด์ค‘๊ฐ(p=0.007)์€ ์ค‘์žฌ ํ›„ ์œ ์˜๋ฏธํ•˜๊ฒŒ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์ฐฝ์ž‘๋ฌด์šฉ ํ”„๋กœ๊ทธ๋žจ ์ฐธ์—ฌ์— ๋Œ€ํ•œ ์‹ฌ์ธต์ธํ„ฐ๋ทฐ๋ฅผ ๋ถ„์„ํ•œ ๊ฒฐ๊ณผ 259๊ฐœ ์›์ž๋ฃŒ, 8๊ฐœ ํ•˜์œ„๋ฒ”์ฃผ, 4๊ฐœ ์ƒ์œ„๋ฒ”์ฃผ๊ฐ€ ๋‚˜ํƒ€๋‚ฌ๋‹ค. ์ƒ์œ„๋ฒ”์ฃผ๋Š” ๊ด€๊ณ„, ์„ฑ์ทจ, ๊ธ์ •์‹ฌ๋ฆฌ, ์ผ์ƒ์—์„œ์˜ ๋ณ€ํ™” ์ด๋‹ค. ์ด๋™์„ฑ ๋ถ„์„ ๊ฒฐ๊ณผ ์ฒซ์งธ, GMFM (๋Œ€๋™์ž‘์šด๋™๊ธฐ๋Šฅ) D ์˜์—ญ(์„œ๊ธฐ, p=0.007)์™€ E ์˜์—ญ(๊ฑท๊ธฐ, ๋‹ฌ๋ฆฌ๊ธฐ, ๋›ฐ๊ธฐ, ๋„์•ฝ, p=0.003)์ด ์œ ์˜๋ฏธํ•˜๊ฒŒ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ๋‘˜์งธ, ๋ณดํ–‰ ์„ ํ˜• ์ง€ํ‘œ์—์„œ๋Š” Opposite foot off(%)(p=0.028), First Double Support(%)(p=0.028)์€ ์ค‘์žฌ ํ›„ ์œ ์˜๋ฏธํ•˜๊ฒŒ ๊ฐ์†Œํ•˜์˜€๊ณ , Single Support(%)(p=0.022)์€ ์œ ์˜๋ฏธํ•˜๊ฒŒ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ๋ณด์žฅ(cm)(p=0.005), ํ™œ๋ณด์žฅ(scm)(p=0.005), ๋ถ„์†์ˆ˜(steps/min)(p=0.009), ๋ณด์†(cm/s)(p=0.005)์€ ์ค‘์žฌ ํ›„ ์œ ์˜๋ฏธํ•˜๊ฒŒ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์…‹์งธ, ๋ณดํ–‰ ์ฃผ๊ธฐ(gait cycle)์—์„œ๋Š” ์ค‘์žฌ ํ›„ ์˜ค๋ฅธ์ชฝ ๊ณ ๊ด€์ ˆ(p=0.009), ์กฑ๊ด€์ ˆ(p=0.03)์˜ ๊ฐ€๋™๋ฒ”์œ„๊ฐ€ ์œ ์˜๋ฏธํ•˜๊ฒŒ ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ๋„ท์งธ, ๋ณดํ–‰ ์‹œ์ (event)์—์„œ๋Š” ์ค‘์žฌ ํ›„ Opposite foot strike(R)(p=0.04)์™€ Foot off(R)(p=0.01) ์‹œ์ ์—์„œ ๊ณ ๊ด€์ ˆ ๊ฐ๋„๊ฐ€ ์œ ์˜๋ฏธํ•˜๊ฒŒ ๊ฐ์†Œํ•˜์˜€๋‹ค. ๋ณดํ–‰ ๊ตฌ๊ฐ„(phase)์—์„œ๋Š” ์ค‘์žฌ ํ›„ Initial double limb support stance ๊ตฌ๊ฐ„์˜ ๊ณ ๊ด€์ ˆ(p=0.002), ์Šฌ๊ด€์ ˆ(p=0.01) ์กฑ๊ด€์ ˆ(p=0.05)์˜ ๋ฒ”์œ„๊ฐ€ ์œ ์˜๋ฏธํ•˜๊ฒŒ ๊ฐ์†Œํ•˜์˜€๋‹ค. Second double limb support stance์—์„œ๋Š” ๊ณ ๊ด€์ ˆ ์ตœ๋Œ€๊ฐ์ด ์œ ์˜๋ฏธํ•˜๊ฒŒ ๊ฐ์†Œ(p=0.017)ํ•˜์˜€๋‹ค. Right lower swingโ… . ์„œ ๋ก  1 1. ์—ฐ๊ตฌ์˜ ํ•„์š”์„ฑ 1 2. ์—ฐ๊ตฌ์˜ ๋ชฉ์  5 3. ์—ฐ๊ตฌ์˜ ๊ฐ€์„ค 5 4. ์šฉ์–ด์˜ ์ •์˜ 7 5. ์—ฐ๊ตฌ์˜ ์ œํ•œ์  9 โ…ก. ์ด๋ก ์  ๋ฐฐ๊ฒฝ 10 1. ๋‡Œ์„ฑ๋งˆ๋น„์™€ ๋ณดํ–‰ 10 ๊ฐ€. ๋ณดํ–‰(Normal Giat)์˜ ํŠน์ง• 10 ๋‚˜. ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์˜ ๋ณดํ–‰ ํŠน์ง• 11 2. ๋™์  ์‹œ์Šคํ…œ ์ด๋ก ๊ณผ ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์˜ ์ค‘์žฌํ™œ๋™ 14 ๊ฐ€. ๋™์  ์‹œ์Šคํ…œ ์ด๋ก ์˜ ๊ฐœ๋… 14 ๋‚˜. ๋™์  ์‹œ์Šคํ…œ ์ด๋ก ์—์„œ์˜ ์›€์ง์ž„ ํ•™์Šต 16 ๋‹ค. ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์˜ ์ค‘์žฌํ™œ๋™ ํ๋ฆ„ 18 3. ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ๊ณผ ์‹ฌ๋ฆฌ์  ์š”์†Œ 22 ๊ฐ€. ์‹ ์ฒด์ƒ 22 ๋‚˜. ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ์˜ ์‹ฌ๋ฆฌ์  ํŠน์ง• 24 ๋‹ค. ์žฅ์• ์ธ๊ณผ ๊ธ์ •์‹ฌ๋ฆฌ 25 4. ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ๊ณผ ๋ฌด์šฉ(Dance) 27 ๊ฐ€. ์ฐฝ์ž‘๋ฌด์šฉ๊ณผ ์›€์ง์ž„ 27 ๋‚˜. ๋ฌด์šฉ๊ณผ ์‹ ๊ฒฝ์žฌํ™œ 29 ๋‹ค. ๋ฌด์šฉ๊ณผ ๊ธ์ •์‹ฌ๋ฆฌ 33 ๋ผ. ๋‡Œ์„ฑ๋งˆ๋น„ ์žฅ์• ์ธ๊ณผ ๋ฌด์šฉ 35 โ…ข. ์—ฐ๊ตฌ ๋ฐฉ๋ฒ• 37 1. ์—ฐ๊ตฌ์ฐธ์—ฌ์ž 37 2. ์—ฐ๊ตฌ ์„ค๊ณ„ 38 3. ์ฐฝ์ž‘๋ฌด์šฉ ํ”„๋กœ๊ทธ๋žจ 41 4. ์ธก์ • ๋ฐฉ๋ฒ• 53 5. ํ†ต๊ณ„์  ๋ถ„์„ 65 โ…ฃ. ์—ฐ๊ตฌ ๊ฒฐ๊ณผ 66 1. ์—ฐ๊ตฌ์ฐธ๊ฐ€์ž์˜ ์ผ๋ฐ˜์  ํŠน์„ฑ 66 2. ์‹ฌ๋ฆฌ์  ๋ณ€์ธ 67 3. ๋Œ€๋™์ž‘์šด๋™๊ธฐ๋Šฅ์˜ ๋ณ€ํ™” 78 4. ๊ณ ๊ด€์ ˆ, ์Šฌ๊ด€์ ˆ, ์กฑ๊ด€์ ˆ์˜ ์ˆ˜๋™๊ด€์ ˆ๊ฐ€๋™๋ฒ”์œ„ ์ฐจ์ด 79 5. ๋ณดํ–‰์„ ํ˜•์ง€ํ‘œ์˜ ์ฐจ์ด 83 6. ํ•˜์ง€ ์šด๋™ํ•™์ ๋ณ€์ธ ์ฐจ์ด 84 7. ๋ณดํ–‰ ์ฃผ๊ธฐ์— ๋”ฐ๋ฅธ ๊ณ ๊ด€์ ˆ, ์Šฌ๊ด€์ ˆ, ์กฑ๊ด€์ ˆ ๊ฐ๋„ ๋ณ€ํ™” 86 8. ๋ณดํ–‰ ์‹œ ๊ณ ๊ด€์ ˆ, ์Šฌ๊ด€์ ˆ, ์กฑ๊ด€์ ˆ์˜ ๊ด€์ ˆ-๊ด€์ ˆ ๋‹ค์ด์–ด๊ทธ๋žจ ํ˜•ํƒœ ๋น„๊ต. 95 โ…ค. ๋…ผ์˜ 100 1. ์‹ฌ๋ฆฌ์  ์š”์ธ์˜ ๋ณ€ํ™” 100 2. ๋Œ€๋™์ž‘์šด๋„๊ธฐ๋Šฅ๊ณผ ๋ณดํ–‰ ๊ธฐ๋Šฅ์˜ ๋ณ€ํ™” 104 โ…ฅ. ๊ฒฐ๋ก  ๋ฐ ์ œ์–ธ 118 1. ๊ฒฐ๋ก . 118 2. ์ œ์–ธ. 119 ์ฐธ๊ณ ๋ฌธํ—Œ 120 Abstract 136 ๋ถ€๋ก 139 1. ์„ค๋ฌธ์ง€. 139 2. ์ฐฝ์ž‘๋ฌด์šฉ ํ”„๋กœ๊ทธ๋žจ 141 3. ์—ฐ๊ตฌ์ฐธ๊ฐ€์ž๋“ค์˜ ๊ด€์ ˆ-๊ด€์ ˆ ๋‹ค์ด์–ด๊ทธ๋žจ์— ๋Œ€ํ•œ ๊ณ ๊ด€์ ˆ, ์Šฌ๊ด€์ ˆ, ์กฑ๊ด€์ ˆ์˜ ๋ณ€ํ™” 174Docto
    • โ€ฆ
    corecore